"Comments","Clinical Code",,,,"Sensitivity Code",,,,"Confidentiality Code",,,
,"CodeSystem Code","CodeSystem Name","Concept Code","Concept Name","System Code","System Display","Code","Display","System Code","System Display","Code","Display"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","S9475","Ambulatory setting substance abuse treatment or detoxification services, per diem","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0014","Alcohol and/or drug services; ambulatory detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0013","Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0012","Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0011","Alcohol and/or drug services; acute detoxification (residential addiction program inpatient)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0010","Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0009","Alcohol and/or drug services; acute detoxification (hospital inpatient)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","H0008","Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.12","CPT-4","4306F","Patient counseled regarding psychosocial and pharmacologic treatment options for opioid addiction (SUD)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87906","Infectious Agent Genotype Analysis By Nucleic Acid (Dna Or Rna); HIV-1, Other Region (Eg, Integrase, Fusion)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87904","Infectious Agent Phenotype Analysis By Nucleic Acid (Dna Or Rna) With Drug Resistance Tissue Culture Analysis, HIV 1; Each Additional Drug Tested (List Separately In Addition To Code For Primary Procedure)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87903","Infectious Agent Phenotype Analysis By Nucleic Acid (Dna Or Rna) With Drug Resistance Tissue Culture Analysis, HIV 1; First Through 10 Drugs Tested","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87901","Infectious Agent Genotype Analysis By Nucleic Acid (Dna Or Rna); HIV-1, Reverse Transcriptase And Protease Regions","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87900","Infectious Agent Drug Susceptibility Phenotype Prediction Using Regularly Updated Genotypic Bioinformatics","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87539","Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-2, Reverse Transcription And Quantification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87538","Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-2, Reverse Transcription And Amplified Probe Technique","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87537","Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-2, Direct Probe Technique","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87536","Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-1, Reverse Transcription And Quantification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87535","Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-1, Reverse Transcription And Amplified Probe Technique","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87534","Infectious Agent Detection By Nucleic Acid (Dna Or Rna); HIV-1, Direct Probe Technique","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87391","Infectious Agent Antigen Detection By Enzyme Immunoassay Technique, Qualitative Or Semiquantitative, Multiple-Step Method; HIV-2","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87390","Infectious Agent Antigen Detection By Enzyme Immunoassay Technique, Qualitative Or Semiquantitative, Multiple-Step Method; HIV-1","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","87389","Infectious Agent Antigen Detection By Enzyme Immunoassay Technique, Qualitative Or Semiquantitative, Multiple-Step Method; HIV-1 Antigen(S), With HIV-1 And HIV-2 Antibodies, Single Result","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","86703","Antibody; HIV-1 And HIV-2, Single Result","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","86702","Antibody; HIV-2","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","86701","Antibody; HIV-1","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","86689","Antibody; Htlv Or HIV Antibody, Confirmatory Test (Eg, Western Blot)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4293F","Patient Screened For High-Risk Sexual Behavior (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4290F","Patient Screened For Injection Drug Use (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4280F","Pneumocystis Jiroveci Pneumonia Prophylaxis Prescribed Within 3 Months Of Low Cd4+ Cell Count Or Percentage (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4279F","Pneumocystis Jiroveci Pneumonia Prophylaxis Prescribed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4276F","Potent Antiretroviral Therapy Prescribed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4274F","Influenza Immunization Administered Or Previously Received (HIV) (P-Esrd)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4271F","Patient Receiving Potent Antiretroviral Therapy For Less Than 6 Months Or Not Receiving Potent Antiretroviral Therapy (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4270F","Patient Receiving Potent Antiretroviral Therapy For 6 Months Or Longer (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","4149F","Hepatitis B Vaccine Injection Administered Or Previously Received (Hep-C, HIV) (Ibd)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3515F","Patient Has Documented Immunity To Hepatitis C (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3514F","Hepatitis C Screening Documented As Performed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3513F","Hepatitis B Screening Documented As Performed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3512F","Syphilis Screening Documented As Performed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3511F","Chlamydia And Gonorrhea Screenings Documented As Performed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3510F","Documentation That Tuberculosis (Tb) Screening Test Performed And Results Interpreted (HIV) (Ibd)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3503F","HIV Rna Viral Load Not Below Limits Of Quantification (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3502F","HIV Rna Viral Load Below Limits Of Quantification (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3500F","Cd4+ Cell Count Or Cd4+ Cell Percentage Documented As Performed (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3498F","Cd4+ Cell Percentage >= 15% (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3497F","Cd4+ Cell Percentage <15% (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3496F","Cd4+ Cell Count >= 500 Cells/Mm3 (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3495F","Cd4+ Cell Count 200 - 499 Cells/Mm3 (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3494F","Cd4+ Cell Count < 200 Cells/Mm3 (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3493F","No History Of Nadir Cd4+ Cell Count < 350 Cells/Mm3 And No History Of AIDS-Defining Condition (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3492F","History Of Nadir Cd4+ Cell Count < 350 Cells/Mm3 (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3491F","HIV Indeterminate (Infants Of Undetermined HIV Status Born Of HIV-Infected Mothers) (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3490F","History Of AIDS-Defining Condition (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","3292F","HIV Testing Ordered Or Documented And Reviewed During The First Or Second Prenatal Visit (Pre-Cr)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.12","CPT-4","0575F","HIV Rna Control Plan Of Care, Documented (HIV)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","HCPCS","HCPCS","S3645","Hiv-1 antibody testing of oral mucosal transudate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","HCPCS","HCPCS","G8500","All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","HCPCS","HCPCS","G8491","I intend to report the hiv/aids measures group","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","HCPCS","HCPCS","G0435","Infectious Agent Antigen Detection By Rapid Antibody Test Of Oral Mucosa Transudate, HIV-1 Or HIV-2, Screening","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","HCPCS","HCPCS","G0433","Infectious Agent Antibody Detection By Enzyme-Linked Immunosorbent Assay (Elisa) Technique, HIV-1 And/Or HIV-2, Screening","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","HCPCS","HCPCS","G0432","Infectious Agent Antibody Detection By Enzyme Immunoassay (Eia) Technique, HIV-1 And/Or HIV-2, Screening","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.99","Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.97","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.96","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.951","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.950","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.94","Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.939","Other psychoactive substance use, unspecified with withdrawal, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.921","Other psychoactive substance use, unspecified with intoxication with delirium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.988 ","Other stimulant use, unspecified with other stimulant-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.982 ","Other stimulant use, unspecified with stimulant-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.981 ","Other stimulant use, unspecified with stimulant-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.980 ","Other stimulant use, unspecified with stimulant-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.959 ","Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.922 ","Other stimulant use, unspecified with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.288 ","Other stimulant dependence with other stimulant-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.282 ","Other stimulant dependence with stimulant-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.281 ","Other stimulant dependence with stimulant-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.280 ","Other stimulant dependence with stimulant-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.259 ","Other stimulant dependence with stimulant-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.222 ","Other stimulant dependence with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.21","Other stimulant dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.20","Other stimulant dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.188 ","Other stimulant abuse with other stimulant-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.182 ","Other stimulant abuse with stimulant-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.181 ","Other stimulant abuse with stimulant-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.180 ","Other stimulant abuse with stimulant-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.159 ","Other stimulant abuse with stimulant-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.122 ","Other stimulant abuse with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F15.10","Other stimulant abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.99","Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.988 ","Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.982 ","Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.981 ","Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.980 ","Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.97","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.96","Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.959 ","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.951","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.950","Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.94","Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.939","Other psychoactive substance use, unspecified with withdrawal, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.922 ","Other psychoactive substance use, unspecified with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.921","Other psychoactive substance use, unspecified with intoxication with delirium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.288 ","Other psychoactive substance dependence with other psychoactive substance-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.282 ","Other psychoactive substance dependence with psychoactive substance-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.281 ","Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.280 ","Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.259 ","Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.222 ","Other psychoactive substance dependence with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.21","Other psychoactive substance dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.20","Other psychoactive substance dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.188 ","Other psychoactive substance abuse with other psychoactive substance-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.182 ","Other psychoactive substance abuse with psychoactive substance-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.181 ","Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.180 ","Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.159 ","Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.122 ","Other psychoactive substance abuse with intoxication with perceptual disturbances","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F19.10","Other psychoactive substance abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.988 ","Cannabis use, unspecified with other Cannabis-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.980 ","Cannabis use, unspecified with anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.959 ","Cannabis use, unspecified with psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.922 ","Cannabis use, unspecified with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.90","Cannabis use, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.288 ","Cannabis dependence with other Cannabis-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.280 ","Cannabis dependence with Cannabis-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.259 ","Cannabis dependence with psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.222 ","Cannabis dependence with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.21","Cannabis dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.20","Cannabis dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.188 ","Cannabis abuse with other Cannabis-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.180 ","Cannabis abuse with Cannabis-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.159 ","Cannabis abuse with psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.122 ","Cannabis abuse with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F12.10","Cannabis abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.988 ","Cocaine use, unspecified with other cocaine-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.982 ","Cocaine use, unspecified with cocaine-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.981 ","Cocaine use, unspecified with cocaine-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.980 ","Cocaine use, unspecified with cocaine-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.959 ","Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.922 ","Cocaine use, unspecified with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.288 ","Cocaine dependence with other cocaine-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.282 ","Cocaine dependence with cocaine-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.281 ","Cocaine dependence with cocaine-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.280 ","Cocaine dependence with cocaine-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.259 ","Cocaine dependence with cocaine-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.222 ","Cocaine dependence with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.21","Cocaine dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.20","Cocaine dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.188 ","Cocaine abuse with other cocaine-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.182","Cocaine abuse with cocaine-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.181 ","Cocaine abuse with cocaine-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.180 ","Cocaine abuse with cocaine-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.159 ","Cocaine abuse with cocaine-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F14.122 ","Cocaine abuse with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.988 ","Hallucinogen use, unspecified with other hallucinogen-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.983 ","Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.980 ","Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.959 ","Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.288 ","Hallucinogen dependence with other hallucinogen-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.283 ","Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.280 ","Hallucinogen dependence with hallucinogen-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.259 ","Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.21","Hallucinogen dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.20","Hallucinogen dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.188 ","Hallucinogen abuse with other hallucinogen-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.183 ","Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.180 ","Hallucinogen abuse with hallucinogen-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.159 ","Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.122 ","Hallucinogen abuse with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F16.10","Hallucinogen abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.988 ","Inhalant use, unspecified with other inhalant-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.982 ","Inhalant use, unspecified with inhalant-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.980 ","Inhalant use, unspecified with inhalant-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.959 ","Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.288 ","Inhalant dependence with other inhalant-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.282 ","Inhalant dependence with inhalant-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.280 ","Inhalant dependence with inhalant-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.259 ","Inhalant dependence with inhalant-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.21","Inhalant dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.20","Inhalant dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.188 ","Inhalant abuse with other inhalant-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.182 ","Inhalant abuse with inhalant-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.180 ","Inhalant abuse with inhalant-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.159 ","Inhalant abuse with inhalant-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F18.10","Inhalant abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.988 ","Opioid use, unspecified with other opioid-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.982 ","Opioid use, unspecified with opioid-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.981 ","Opioid use, unspecified with opioid-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.959 ","Opioid use, unspecified with opioid-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.922 ","Opioid use, unspecified with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.288 ","Opioid dependence with other opioid-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.282 ","Opioid dependence with opioid-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.281 ","Opioid dependence with opioid-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.259 ","Opioid dependence with opioid-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.222 ","Opioid dependence with intoxication with perceptual disturbance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.21","Opioid dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.20","Opioid dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.188 ","Opioid abuse with other opioid-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.182","Opioid abuse with opioid-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.181 ","Opioid abuse with opioid-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.159 ","Opioid abuse with opioid-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F11.10","Opioid abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.988 ","Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.982 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.981 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.980 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.959 ","Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.288 ","Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.282 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.281 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.280 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.259 ","Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.21","Sedative, hypnotic, or anxiolytic dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.20","Sedative, hypnotic, or anxiolytic dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.188 ","Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.182 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.181 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.180 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.159 ","Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","ICD-10-CM ","ICD-10-Clinical Modification","F13.10","Sedative, hypnotic, or anxiolytic abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.982 ","Alcohol use, unspecified with alcohol-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.980 ","Alcohol use, unspecified with alcohol-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.96","Alcohol use, unspecified with alcohol-induced persisting amnestic disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.959 ","Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.951","Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.950","Alcohol use, unspecified with alcohol-induced psychotic disorder with delusion","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.929","Alcohol use, unspecified with intoxication, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.288 ","Alcohol dependence with other alcohol-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.282 ","Alcohol dependence with alcohol-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.281 ","Alcohol dependence with alcohol-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.280 ","Alcohol dependence with alcohol-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.27","Alcohol dependence with alcohol-induced persisting dementia","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.259 ","Alcohol dependence with alcohol-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.239","Alcohol dependence with withdrawal, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.231","Alcohol dependence with withdrawal delirium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.229","Alcohol dependence with intoxication, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.21","Alcohol dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.20","Alcohol dependence, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.188 ","Alcohol abuse with other alcohol-induced disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.182","Alcohol abuse with alcohol-induced sleep disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.181 ","Alcohol abuse with alcohol-induced sexual dysfunction","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.180 ","Alcohol abuse with alcohol-induced anxiety disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.159 ","Alcohol abuse with alcohol-induced psychotic disorder, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","ICD-10-CM ","ICD-10-Clinical Modification","F10.10","Alcohol abuse, uncomplicated","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.73","Amphetamine or related acting sympathomimetic abuse, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.72","Amphetamine or related acting sympathomimetic abuse, episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.71","Amphetamine or related acting sympathomimetic abuse, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.7","Amphetamine or related acting sympathomimetic abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.7","Amphetamine or related acting sympathomimetic abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.43","Amphetamine and other psychostimulant dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.42","Amphetamine and other psychostimulant dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.41","Amphetamine and other psychostimulant dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.4","Amphetamine and other psychostimulant dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.4","Amphetamine and other psychostimulant dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.23","Cannabis abuse-in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.22","Cannabis abuse-episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.21","Cannabis abuse-continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.2","Nondependent Cannabis abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.2","Nondependent Cannabis abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.33","Cannabis dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.32","Cannabis dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.31","Cannabis dependence, continuousa","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.3","Cannabis t dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.3","Cannabis t dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.2","Pathological drug intoxication","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.63","Cocaine abuse-in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.62","Cocaine abuse-episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.61","Cocaine abuse-continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.6","Cocaine Abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.6","Nondependent cocaine abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.23","Cocaine dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.22","Cocaine dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.21","Cocaine dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.2","Cocaine dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.2","Cocaine dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.9","Unspecified drug-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.9","Unspecified drug-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.89","Other specified drug-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.85","Drug induced sleep disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.84","Drug-induced mood disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.83","Drug-induced persisting amnestic disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.82","Drug-induced persisting dementia","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.81","Drug-induced delirium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.8","Other specified drug-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.8","Other specified drug-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.2","Pathological drug intoxication","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.2","Pathological drug intoxication","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.12","Drug-induced psychotic disorders with hallucinations","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.11","Drug-induced psychotic disorders with delusions","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292.1","Drug-induced psychotic disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292","Drug withdrawal","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","292","Drug-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.33","Hallucinogen abuse-in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.32","Hallucinogen abuse-episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.31","Hallucinogen abuse-continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.3","Hallucinogen Abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.3","Nondependent hallucinogen abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.53","Hallucinogen dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.52","Hallucinogen dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.51","Hallucinogen dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.5","Hallucinogen dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.5","Hallucinogen and other psychostimulantt dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.93","Other, mixed, or unspecified drug abuse, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.92","Other, mixed, or unspecified drug abuse, episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.91","Other, mixed, or unspecified drug abuse, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.9","Other, mixed, or unspecified drug abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.9","Nondependent other mixed or unspecified drug abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.63","Other specified drug dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.62","Other specified drug dependence, episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.61","Other specified drug dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.6","Other specified drug dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.6","Other specified drug dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.53","Opioid abuse-in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.52","Opioid abuse-episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.51","Opioid abuse-continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.5","Opioid Abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.5","Opioid Abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.73","Combinations of opioid type drug with any other drug dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.72","Combinations of opioid type drug with any other drug dependence, episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.71","Combinations of opioid type drug with any other drug dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.7","Combinations of opioid type drug with any other drug dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.7","Combinations of opioid type drug with any other drug dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.03","Opioid dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.02","Opioid dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.01","Opioid dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304","Opioid dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304","Opioid dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.43","Sedative, hypnotic, or anxiolytic abuse-in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.42","Sedative, hypnotic, or anxiolytic abuse-episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.41","Sedative, hypnotic, or anxiolytic abuse-continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.4","Sedative, hypnotic, or anxiolytic Abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.4","Nondependent Sedative, hypnotic, or anxiolytic abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.13","Sedative, hypnotic, or anxiolytic dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.12","Sedative, hypnotic, or anxiolytic dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.11","Sedative, hypnotic, or anxiolytic dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.1","Sedative, hypnotic, or anxiolytic dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","304.1","Sedative, hypnotic, or anxiolytic dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.69","Combined alcohol and drug rehabilitation and detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.68","Combined alcohol and drug detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.67","Combined alcohol and drug rehabilitation","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.66","Drug rehabilitation and detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.65","Drug detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.64","Drug rehabilitation","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.63","Alcohol rehabilitation and detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.62","Alcohol detoxification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","94.61","Alcohol rehabilitation","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","V65.44","Human Immunodeficiency Virus (Hiv) Counseling","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","V08","Hiv Infection, Asymptomatic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","795.71","Nonspecific serologic evidence of human immunodeficiency virus [HIV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","79.53","Human Immunodeficiency Virus, Type 2 (HIV 2), in Conditions Classified Elsewhere and of Unspecified Site","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","042","Human immunodeficiency virus [HIV] disease","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","042.","Human immunodeficiency virus [HIV] disease","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","294.1","AIDS Dementia Complex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.03","Alcohol abuse-in remiss.","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.02","Alcohol abuse-episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305.01","Alcohol abuse-continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305","Alcohol Abuse, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","305","Nondependent alcohol abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.93","Other and unspecified alcohol dependence, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.92","Other and unspecified alcohol dependence , episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.91","Other and unspecified alcohol dependence, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.9","Other and unspecified alcohol dependence, unspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.9","Other and unspecified alcohol dependence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.03","Acute alcoholic intoxication in alcoholism, in remission","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.02","Acute alcoholic intoxication in alcoholism, episodic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303.01","Acute alcoholic intoxication in alcoholism, continuous","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303","Acute alcoholic intoxication in alcoholism, uspecified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303","Acute alcoholic intoxication","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","303","Alcohol dependence syndrome","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.9","Unspecified alcohol-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.89","Other specified alcohol-induced mental disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.82","Alcohol induced sleep disorders","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.81","Alcohol withdrawal","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.5","Alcohol-induced psychotic disorder with delusions","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.4","Idiosyncratic alcohol intoxication","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.3","Alcohol-induced psychotic disorder with hallucinations","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.2","Alcohol-induced persisting dementia","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291.1","Alcohol-induced persisting amnestic disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291","Alcohol withdrawal delirium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD-9-Clinical Modification","291","Alcohol withdrawal delirium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99852-3","Benzylpiperazine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99793-9","Benzylpiperazine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP71389-8","Chloroamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69763-8","Amphetamine+Methamphetamine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69733-1","Amphetamine+Methamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69732-3","Amphetamine+Methamphetamine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69685-3","Amphetamine+Methamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54800-5","Amphetamines | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54797-3","Amphetamines | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52056-6","Methamphetamine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52053-3","Amphetamines | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52011-1","Methamphetamine | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51949-3","Methylenedioxyamphetamine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51948-5","Amphetamines | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51930-3","Methylenedioxymethamphetamine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51892-5","Methamphetamine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51843-8","Pholedrine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51821-4","Phendimetrazine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51734-9","Methylenedianiline | Air","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51335-5","Methylphenidate | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51278-7","Furfenorex | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51273-8","Fenproporex | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51269-6","Fenetylline | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50882-7","Clobenzorex | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50416-4","Alpha-phenyl-2-piperidine Acetate | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50415-6","Amphetaminil | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50411-5","Amphetamines | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50129-3","Dextromethamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50128-5","Dextroamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49898-7","Alpha-phenyl-2-piperidine Acetate | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49557-9","Levoamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49165-1","Phendimetrazine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49154-5","Methylenedioxyethylamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49150-3","Amphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49114-9","Amphetamines | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48761-8","Methylenedianiline | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48722-0","Phendimetrazine | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48718-8","Methylenedioxyethylamphetamine | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48704-8","Methylenedioxyamphetamine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48689-1","Amphetamines | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48678-4","Methylenedioxyamphetamine | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48677-6","Methylenedioxymethamphetamine | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48672-7","Phendimetrazine | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48649-5","Methamphetamine | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48645-3","Amphetamines | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48644-6","Phendimetrazine | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48636-2","Methylenedioxyethylamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48632-1","Methylenedioxyethylamphetamine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48631-3","Methylenedioxyethylamphetamine | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48625-5","Methylenedioxyethylamphetamine | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48573-7","Amphetamine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48532-3","Amphetamines | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48485-4","Methylenedioxymethamphetamine | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48484-7","Methylenedioxyamphetamine | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48483-9","Amphetamine | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48464-9","Methylenedioxyamphetamine | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48462-3","Methamphetamine | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48445-8","Phendimetrazine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48222-1","Methamphetamine | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46221-5","Para Hydroxyamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46215-7","Methylphenidate | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46203-3","Dimetamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45784-3","Methylenedioxyamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45782-7","Methylenedioxymethamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45781-9","Methylenedioxyamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45310-7","Methylenedianiline | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45300-8","Methamphetamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44655-6","Methamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44654-9","Amphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44639-0","Ethylamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44051-8","Methamphetamine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43676-3","Methamphetamine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43255-6","Amphetamines | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43225-9","Methylenedioxymethamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42699-6","Dextroamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42023-9","Levomethamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42022-1","Dextromethamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41899-3","Amphetamines | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41878-7","Phenethylamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP31526-4","Amphetamine+Methamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP29634-0","Alpha-Phenyl-2-Piperidine acetate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP21172-9","Methylenedioxyethylamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP19426-3","Dextromethamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP19292-9","Methylenedioxyamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP19144-2","Methylenedianiline","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18868-7","Amphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18612-9","Methylenedioxymethamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18064-3","Phenethylamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18019-7","Dextroamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP163969-1","Methylone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16254-2","Pholedrine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16245-0","Phendimetrazine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16234-4","Para hydroxyamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16202-1","Methylphenidate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16194-0","Methamphetamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16154-4","Furfenorex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16147-8","Fenproporex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16144-5","Fenetylline","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16081-9","Clobenzorex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16035-5","Amphetaminil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16034-8","Amphetamines","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158117-4","Amphetamine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158103-4","Methylenedioxyamphetamine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP145348-1","2,5-dimethoxy-4-bromoamphetamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP135765-8","Methylenedioxymethamphetamine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP134010-0","Mephedrone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102280-7","Alpha-Phenyl-2-Piperidine acetate | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102275-7","Methylphenidate | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102274-0","Methylenedioxymethamphetamine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102273-2","Methylenedioxyethylamphetamine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102260-9","Alpha-Phenyl-2-Piperidine acetate | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102256-7","Methylphenidate | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102255-9","Methylenedioxyethylamphetamine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102254-2","Methylenedioxyamphetamine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100108-2","Benzylpiperazine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","9814-5","Dextroamphetamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","9352-6","Amphetamines [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8156-2","Amphetamines [Presence] in Unknown substance by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8155-4","Amphetamines [Presence] in Unknown substance by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8154-7","Amphetamines [Presence] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8153-9","Amphetamines [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8152-1","Amphetamines [Presence] in Urine by SAMHSA screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8151-3","Amphetamines [Presence] in Urine by SAMHSA confirm method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8150-5","Amphetamines [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8149-7","Amphetamines [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8148-9","Amphetamines [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8147-1","Amphetamines [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8146-3","Amphetamines [Presence] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8145-5","Amphetamines [Presence] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8144-8","Amphetamines [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8143-0","Amphetamines [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8142-2","Amphetamines [Presence] in Gastric fluid by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8141-4","Amphetamines [Presence] in Gastric fluid by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8140-6","Amphetamines [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8139-8","Amphetamines [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73686-8","Methylone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72796-6","Mephedrone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72795-8","Mephedrone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72794-1","Methylone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72793-3","Methylone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72792-5","Methylphenidate/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72791-7","Alpha-Phenyl-2-Piperidine acetate/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72790-9","Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72758-6","Amphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72736-2","Methylenedioxyamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72735-4","Methamphetamine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70138-3","Amphetamines [Mass/volume] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69798-7","2,5-dimethoxy-4-bromoamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69025-5","Methylenedioxymethamphetamine [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69024-8","Methylenedioxyethylamphetamine [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69023-0","Methylenedioxyamphetamine [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69022-2","Methamphetamine [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","67838-3","Mephedrone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","66127-2","Amphetamine [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","64233-0","Benzylpiperazine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","64138-1","Methylenedioxyamphetamine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","64127-4","Methylenedioxyethylamphetamine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61090-7","Alpha-Phenyl-2-Piperidine acetate [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61084-0","Methylphenidate [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61083-2","Methylenedioxymethamphetamine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61082-4","Methylenedioxyethylamphetamine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61059-2","Alpha-Phenyl-2-Piperidine acetate [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61058-4","Alpha-Phenyl-2-Piperidine acetate [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61050-1","Methylphenidate [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61049-3","Methylenedioxyethylamphetamine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61048-5","Methylenedioxyethylamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61047-7","Methylenedioxyethylamphetamine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61046-9","Methylenedioxyamphetamine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61045-1","Methylenedioxyamphetamine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59844-1","Methylenedioxyethylamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59837-5","Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59287-3","Benzylpiperazine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59286-5","Benzylpiperazine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59285-7","Benzylpiperazine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59135-4","Benzylpiperazine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58925-9","Dextromethamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58358-3","Methamphetamine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58357-5","Amphetamine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","56120-9","Amphetamine+Methamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55587-0","Methamphetamine [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55552-4","Methylphenidate [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55551-6","Methylenedioxyamphetamine [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","53821-5","Chloroamphetamine [Mass/volume] in Serum","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","52957-8","Amphetamine [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51690-6","Amphetamines [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48939-3","Amphetamines [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","45143-5","Methylenedioxyethylamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","44424-0","Methylenedioxymethamphetamine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43983-6","Amphetamines [Presence] in Urine by Screen method >500 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43934-9","Amphetamines [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43860-6","Amphetamine+Methamphetamine [Presence] in Gastric fluid by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42576-9","Amphetamine [Mass/volume] in Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42253-5","Methylenedioxyamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41464-9","Amphetamines/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40804-7","Methamphetamine [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40803-9","Methamphetamine [Presence] in Hair by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40799-9","Amphetamines [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40798-1","Amphetamines [Presence] in Hair by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40652-0","Methamphetamine [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40531-6","Methylenedioxyamphetamine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40529-0","Amphetamines [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40493-9","Methylenedioxymethamphetamine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40481-4","Methylenedioxymethamphetamine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40421-0","Amphetamine+Methamphetamine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40420-2","Amphetamine+Methamphetamine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40419-4","Amphetamine+Methamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40381-6","Methamphetamine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3970-1","Pholedrine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3941-2","Phendimetrazine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3940-4","Phendimetrazine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3939-6","Phendimetrazine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3938-8","Phendimetrazine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3903-2","Para hydroxyamphetamine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3902-4","Para hydroxyamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3901-6","Para hydroxyamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","38748-0","Methylenedianiline [Mass/volume] in Air","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3810-9","Methylphenidate [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3809-1","Methylphenidate [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3808-3","Methylphenidate [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3807-5","Methylphenidate [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3806-7","Methylphenidate [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3780-4","Methamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3779-6","Methamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3778-8","Methamphetamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3777-0","Methamphetamine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3776-2","Methamphetamine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3658-2","Furfenorex [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3657-4","Furfenorex [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3656-6","Furfenorex [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3635-0","Fenproporex [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3634-3","Fenproporex [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3633-5","Fenproporex [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3629-3","Fenetylline [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3628-5","Fenetylline [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3627-7","Fenetylline [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3566-7","Dimetamphetamine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3565-9","Dimetamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3564-2","Dimetamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3489-2","Clobenzorex [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3488-4","Clobenzorex [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33646-1","Methylenedianiline [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3352-2","Amphetaminil [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3351-4","Amphetaminil [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33507-5","Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3350-6","Amphetaminil [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3349-8","Amphetamines [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3348-0","Amphetamines [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33280-9","Amphetamine+Methamphetamine [Mass/volume] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33016-7","Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32643-9","Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32642-1","Dextroamphetamine/Levoamphetamine [Mass Ratio] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32153-9","Alpha-Phenyl-2-Piperidine acetate [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31026-8","Dextromethamphetamine/Amphetamines.total in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31025-0","Dextroamphetamine/Amphetamines.total in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31016-9","Levoamphetamine/Amphetamines.total in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","30112-7","Amphetamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29619-4","Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29613-7","Phendimetrazine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29599-8","Methylenedioxyethylamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29598-0","Methylenedioxyamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29592-3","Amphetamine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29530-3","Amphetamines [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29286-2","Methamphetamine [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27409-2","Methylenedianiline [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27303-7","Phendimetrazine [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27299-7","Methylenedioxyethylamphetamine [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27289-8","Methamphetamine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27277-3","Methamphetamine [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27263-3","Amphetamines [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27244-3","Methylenedioxyamphetamine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27205-4","Amphetamines [Presence] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27189-0","Methylenedioxyamphetamine [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27188-2","Methylenedioxymethamphetamine [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27178-3","Phendimetrazine [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27116-3","Methamphetamine [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27105-6","Amphetamines [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27102-3","Phendimetrazine [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27085-0","Methylenedioxyethylamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27080-1","Methylenedioxyethylamphetamine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27079-3","Methylenedioxyethylamphetamine [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27074-4","Methylenedioxyethylamphetamine [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26959-7","Amphetamine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26895-3","Amphetamines [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26793-0","Methylenedioxymethamphetamine [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26792-2","Methylenedioxyamphetamine [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26791-4","Amphetamine [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26742-7","Methylenedioxyamphetamine [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26734-4","Methamphetamine [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26711-2","Phendimetrazine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","21386-8","Methamphetamine [Presence] in Urine by SAMHSA confirm method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20554-2","Para hydroxyamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20548-4","Methylphenidate [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20546-8","Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20545-0","Methylenedioxyamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20526-0","Dimetamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20525-2","Dextroamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20410-7","Amphetamines [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19654-3","Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19653-5","Para hydroxyamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19652-7","Para hydroxyamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19651-9","Para hydroxyamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19580-0","Methylphenidate cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19579-2","Methylphenidate cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19578-4","Methylphenidate [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19577-6","Methylphenidate [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19572-7","Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19571-9","Methylenedioxymethamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19570-1","Methylenedioxymethamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19569-3","Methylenedioxymethamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19568-5","Methylenedioxymethamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19567-7","Methylenedioxyamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19566-9","Methylenedioxyamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19565-1","Methylenedioxyamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19557-8","Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19556-0","Methamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19555-2","Methamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19554-5","Methamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19515-6","Levomethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19514-9","Levomethamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19512-3","Levomethamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19511-5","Levomethamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19510-7","Levomethamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19461-3","Ethylamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19460-5","Ethylamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19459-7","Ethylamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19458-9","Ethylamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19456-3","Ethylamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19455-5","Dimetamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19454-8","Dimetamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19453-0","Dimetamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19452-2","Dimetamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19428-2","Dextromethamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19427-4","Dextromethamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19425-8","Dextromethamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19424-1","Dextromethamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19423-3","Dextromethamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19422-5","Dextroamphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19421-7","Dextroamphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19420-9","Dextroamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19419-1","Dextroamphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19348-2","Amphetamine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19347-4","Amphetamine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19346-6","Amphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19344-1","Amphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19343-3","Amphetamine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19269-0","Amphetamines confirm method [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19268-2","Amphetamines screen method [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19267-4","Amphetamines cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19266-6","Amphetamines cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19263-3","Amphetamines tested for in Urine by Screen method Narrative","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19262-5","Amphetamines tested for in Urine by Screen method Nominal","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19261-7","Amphetamines [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19059-5","Amphetamines cutoff [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18431-7","Amphetamines [Presence] in Stool by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18359-0","Methylenedioxyamphetamine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18358-2","Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18357-4","Methylenedioxymethamphetamine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18356-6","Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18355-8","Methylenedioxyamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17272-6","Methylenedianiline [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17260-1","Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16369-1","Amphetamines [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16235-4","Methamphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16234-7","Amphetamine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16212-3","Ethylamphetamine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15405-4","Methamphetamine [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15404-7","Levomethamphetamine/Amphetamines.total in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15366-8","Dextroamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14834-6","Methamphetamine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14309-9","Amphetamines [Presence] in Urine by Confirm method >200 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14308-1","Amphetamines [Presence] in Urine by Screen method >1000 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14267-9","Methylenedioxymethamphetamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","13498-1","Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","13497-3","Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12478-4","Levomethamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12477-6","Dextromethamphetamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12350-5","Amphetamines [Presence] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12331-5","Phenethylamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP65459-7","Cannabinoids | Dialysis fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP63561-2","Carboxy Tetrahydrocannabinol | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP63560-4","Cannabinoids | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP63556-2","11-Hydroxy delta-9 tetrahydrocannabinol | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP63097-7","Tetrahydrocannabinol | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54804-7","Tetrahydrocannabinol | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54803-9","Tetrahydrocannabinol | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52978-1","Tetrahydrocannabinol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52872-6","Tetrahydrocannabinol | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52078-0","11-Hydroxy delta-9 tetrahydrocannabinol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52054-1","Cannabinoids | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50443-8","Cannabinoids | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49616-3","Carboxy Tetrahydrocannabinol | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49063-8","Carboxy Tetrahydrocannabinol | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48694-1","Carboxy Tetrahydrocannabinol | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48637-0","Cannabinoids | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48601-6","Cannabinoids | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48512-5","Cannabinoids | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48468-0","Cannabinoids | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48461-5","Carboxy Tetrahydrocannabinol | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46058-1","Carboxy Tetrahydrocannabinol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45738-9","Cannabinoids | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44794-3","Cannabinoids | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44656-4","Cannabinoids | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44610-1","Carboxy Tetrahydrocannabinol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42683-0","Tetrahydrocannabinol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41902-5","Tetrahydrocannabinol | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP35627-6","11-Hydroxy delta-9 tetrahydrocannabinol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP182207-3","JWH-073 (synthetic cannabinoid) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP182173-7","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP181189-4","JWH-200 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180956-7","JWH-018 pentanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180938-5","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180879-1","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180794-2","JWH-122 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180611-8","RCS-4 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180426-1","JWH-250 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180020-2","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179864-6","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179855-4","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179814-1","JWH-018 carboxylated (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179615-2","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179303-5","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179235-9","Cannabinoids synthetic | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179179-9","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179035-3","JWH-073 butanol (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178806-8","MAM-2201 pentanoate (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178805-0","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178789-6","UR-144 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178788-8","MAM-2201 pentanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178592-4","UR-144 pentanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178591-6","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178590-8","JWH-073 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178589-0","JWH-018 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178588-2","JWH-018 (synthetic cannabinoid) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178523-9","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178489-3","JWH-073 carboxylated (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178378-8","JWH-018 pentanol (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178331-7","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178330-9","JWH-018 pentanoate (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178329-1","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178305-1","MAM-2201 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178154-3","JWH-073 butanoate (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177768-1","UR-144 pentanoate (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177683-2","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177682-4","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177659-2","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177547-9","JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177544-6","JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177416-7","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177415-9","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177283-1","AM-2201 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177282-3","JWH-398 (synthetic cannabinoid) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177281-5","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP177280-7","JWH-073 butanoate (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP176890-4","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP176889-6","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP176693-2","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP176666-8","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172814-8","UR-144 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172813-0","RCS-4 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172812-2","MAM-2201 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172811-4","JWH-398 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172810-6","JWH-250 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172809-8","JWH-200 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172808-0","JWH-122 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172807-2","AM-2201 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172775-1","JWH-073 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172774-4","JWH-018 (synthetic cannabinoid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16059-5","Tetrahydrocannabinol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16058-7","Cannabinoids","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158121-6","Carboxy tetrahydrocannabinol | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157591-1","Cannabinoids synthetic | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157300-7","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157299-1","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157298-3","UR-144 pentanoate (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157297-5","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157296-7","MAM-2201 pentanoate (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157295-9","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157294-2","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157292-6","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157291-8","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157290-0","JWH-073 butanoate (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157289-2","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157288-4","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157287-6","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157286-8","JWH-018 pentanoate (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157282-7","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157281-9","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14468-0","Carboxy tetrahydrocannabinol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP130325-6","Cannabinoids synthetic | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP130276-1","Cannabinoids synthetic","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/9/8172","Cannabinoids [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/9/8167","Tetrahydrocannabinol [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8176-0","Cannabinoids [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8162-0","Tetrahydrocannabinol [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/8/8177","Cannabinoids [Presence] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/8/8163","Tetrahydrocannabinol [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74157-9","Cannabinoids [Presence] in Serum, Plasma or Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73957-3","UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73956-5","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73955-7","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73954-0","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73953-2","JWH-073 (Synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73952-4","AM-2201 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73951-6","RCS-4 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73950-8","JWH-250 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73949-0","JWH-018 (Synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73948-2","JWH-122 (Synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73947-4","JWH-398 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73946-6","JWH-200 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73945-8","UR-144 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73944-1","MAM-2201 (synthetic cannabinoid) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73943-3","Cannabinoids synthetic [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73935-9","Tetrahydrocannabinol [Mass/volume] in Serum, Plasma or Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73930-0","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73929-2","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73928-4","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73927-6","JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73926-8","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73925-0","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73924-3","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73923-5","JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73922-7","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73921-9","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73920-1","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73919-3","MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73918-5","JWH-073 (Synthetic cannabinoid) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73917-7","JWH-250 4/5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73914-4","JWH-018 (Synthetic cannabinoid) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72875-8","JWH-073 butanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72874-1","JWH-073 butanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72818-8","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72817-0","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72809-7","JWH-018 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72808-9","JWH-018 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72807-1","JWH-073 carboxylated (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72806-3","JWH-073 carboxylated (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72805-5","JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72804-8","JWH-210 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72803-0","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72802-2","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72783-4","JWH-018 pentanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72782-6","JWH-018 pentanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72781-8","JWH-018 pentanol (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72780-0","JWH-018 pentanol (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72779-2","JWH-073 butanoate (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72778-4","JWH-073 butanoate (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72764-4","Carboxy tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72474-0","JWH-122 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72473-2","JWH-398 5 hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72472-4","UR-144 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72471-6","UR-144 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72470-8","MAM-2201 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72469-0","RCS-4 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72468-2","RCS-4 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72467-4","JWH-250 5-carboxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72466-6","JWH-250 5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72465-8","JWH-073 butanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72464-1","JWH-073 4-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72463-3","AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72462-5","JWH-200 4-hydroxyindole (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72461-7","JWH-018 pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72460-9","JWH-073 3-hydroxybutyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72459-1","JWH-018 4/5-hydroxypentyl (synthetic cannabinoid metabolites) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72379-1","Cannabinoids synthetic [Presence] in Unspecified specimen by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70178-9","11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70145-8","Cannabinoids [Presence] in Urine by Screen method >50 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70144-1","Cannabinoids [Presence] in Urine by Screen method >20 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70143-3","Cannabinoids [Mass/volume] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/7/8168","Tetrahydrocannabinol [Presence] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/7/3528","Tetrahydrocannabinol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69007-3","Carboxy tetrahydrocannabinol [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","67126-3","Cannabinoids synthetic [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61063-4","Carboxy tetrahydrocannabinol [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61062-6","Carboxy tetrahydrocannabinol [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/6/8178","Cannabinoids [Presence] in Unknown substance by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/6/8164","Tetrahydrocannabinol [Presence] in Gastric fluid by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/6/3425","Cannabinoids [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59573-6","Cannabinoids [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59160-2","Cannabinoids [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58047-2","Tetrahydrocannabinol [Presence] in Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57924-3","Carboxy tetrahydrocannabinol [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","52954-5","Cannabinoids [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51791-2","Tetrahydrocannabinol [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","50406-8","Cannabinoids [Presence] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","50338-3","Cannabinoids [Mass/volume] in Dialysis fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/5/8174","Tetrahydrocannabinol [Presence] in Urine by SAMHSA confirm method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/5/8169","Tetrahydrocannabinol [Presence] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/5/3435","Carboxy tetrahydrocannabinol [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49746-1","Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48944-3","Carboxy tetrahydrocannabinol [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48943-5","Cannabinoids [Presence] in Unspecified specimen by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48942-7","Cannabinoids [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48935-1","11-Hydroxy delta-9 tetrahydrocannabinol [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48934-4","11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","47386-8","Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","44049-5","Tetrahydrocannabinol [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43834-1","Tetrahydrocannabinol [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42860-7","Cannabinoids [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42630-4","Cannabinoids [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42492-9","Carboxy tetrahydrocannabinol [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42491-1","Cannabinoids [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40864-1","11-Hydroxy delta-9 tetrahydrocannabinol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40801-3","Cannabinoids [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40800-5","Cannabinoids [Presence] in Hair by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/4/8179","Cannabinoids [Presence] in Unknown substance by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/4/3426","Tetrahydrocannabinol [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33561-2","Cannabinoids [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33282-5","Cannabinoids [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31136-5","Carboxy tetrahydrocannabinol [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31080-5","Cannabinoids [Presence] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/3/8170","Cannabinoids [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/3/8165","Tetrahydrocannabinol [Presence] in Gastric fluid by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/3/3530","Tetrahydrocannabinol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/3/3436","Carboxy tetrahydrocannabinol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29326-6","Carboxy tetrahydrocannabinol [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27213-8","Carboxy tetrahydrocannabinol [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27193-2","Tetrahydrocannabinol [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27086-8","Cannabinoids [Presence] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27024-9","Cannabinoids [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26995-1","Carboxy tetrahydrocannabinol [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26893-8","Tetrahydrocannabinol [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26856-5","Cannabinoids [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26764-1","Cannabinoids [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26747-6","Cannabinoids/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26743-5","Carboxy tetrahydrocannabinol [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26732-8","Carboxy tetrahydrocannabinol [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26731-0","Tetrahydrocannabinol [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","21557-4","Tetrahydrocannabinol [Presence] in Urine by Screen method >100 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","21556-6","Tetrahydrocannabinol [Presence] in Urine by Screen method >20 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20521-1","Carboxy tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20413-1","Cannabinoids [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/2/8175","Tetrahydrocannabinol [Presence] in Urine by SAMHSA screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/2/3427","Cannabinoids [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19418-3","Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19417-5","Tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19416-7","Tetrahydrocannabinol [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19415-9","Tetrahydrocannabinol [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19384-7","Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19383-9","Carboxy tetrahydrocannabinol cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19382-1","Carboxy tetrahydrocannabinol [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19381-3","Carboxy tetrahydrocannabinol [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19294-8","Cannabinoids confirm method [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19293-0","Cannabinoids screen method [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19292-2","Cannabinoids cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19291-4","Cannabinoids cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19289-8","Cannabinoids [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19288-0","Cannabinoids tested for in Urine by Screen method Narrative","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19287-2","Cannabinoids tested for in Urine by Screen method Nominal","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19073-6","Cannabinoids cutoff [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19055-3","Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18432-5","Tetrahydrocannabinol [Presence] in Stool by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18282-4","Cannabinoids [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17872-3","Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16543-1","Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16542-3","Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16243-8","Cannabinoids [Mass/volume] in Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16150-5","Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14313-1","Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14312-3","Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","13478-3","Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12351-3","Tetrahydrocannabinol [Presence] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/1/8171","Cannabinoids [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1/1/8166","Tetrahydrocannabinol [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP53326-2","2-oxo-3-hydroxy-lysergate diethylamide | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51310-8","Lysergate Diethylamide | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51161-5","Dimethyltryptamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45825-4","Psilocin | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45559-9","Tryptamine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45438-6","Psilocybin | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45437-8","Psilocybin | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44641-6","Lysergate Diethylamide | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44609-3","Psilocin | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44608-5","Mescaline | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43534-4","Bufotenine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41988-4","Bufotenine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41841-5","Mescaline | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41840-7","Hallucinogens | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41836-5","Dimethyltryptamine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18864-6","Psilocin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18049-4","Hallucinogens","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180335-4","NBOMe | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180251-3","25H-NBOMe | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP17987-6","Mescaline","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179577-4","2C-C-NBOMe | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179484-3","25I-NBOMe | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179322-5","Lysergate diethylamide | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178302-8","Lysergate diethylamide | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP173524-2","NBOMe","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP17245-9","Psilocybin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16809-3","Bufotenine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16179-1","Lysergate diethylamide","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16115-5","Dimethyltryptamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102283-1","Lysergate diethylamide | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102261-7","Lysergate diethylamide | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100139-7","Salvinorin B | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100138-9","Salvinorin A | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100137-1","Salvinorin B | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100136-3","Salvinorin A | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100050-6","Salvinorin B","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100049-8","Salvinorin A","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","9726-1","Mescaline [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74001-9","NBOMe [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74000-1","25I-NBOMe [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73999-5","2C-C-NBOMe [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73998-7","25H-NBOMe [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73730-4","Lysergate diethylamide [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73726-2","Lysergate diethylamide [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","6930-2","Psilocybin [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61094-9","Lysergate diethylamide [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61065-9","Lysergate diethylamide [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59329-3","Salvinorin B [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59328-5","Salvinorin A [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59327-7","Salvinorin B [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59326-9","Salvinorin A [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59325-1","Salvinorin B [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59324-4","Salvinorin A [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","5679-6","Lysergate diethylamide [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","5678-8","Lysergate diethylamide [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","5608-5","Bufotenine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","45185-6","2-Oxo-3-Hydroxy-Lysergate diethylamide [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3732-5","Lysergate diethylamide [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3731-7","Lysergate diethylamide [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3730-9","Lysergate diethylamide [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3568-3","Dimethyltryptamine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3567-5","Dimethyltryptamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33350-0","Lysergate diethylamide [Mass/volume] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20558-3","Psilocin [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20543-5","Mescaline [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20542-7","Lysergate diethylamide [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19691-5","Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19690-7","Psilocybin cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19688-1","Psilocybin [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19687-3","Psilocybin [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19686-5","Psilocybin [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19685-7","Psilocin cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19684-0","Psilocin cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19683-2","Psilocin [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19682-4","Psilocin [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19545-3","Mescaline cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19544-6","Mescaline cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19543-8","Mescaline [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19542-0","Mescaline [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19531-3","Lysergate diethylamide cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19530-5","Lysergate diethylamide cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19528-9","Lysergate diethylamide [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18415-0","Psilocin [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18414-3","Psilocin [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17751-9","Tryptamine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17505-9","Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17504-2","Psilocybin [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16214-9","Lysergate diethylamide [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16146-3","Psilocin [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16145-5","Mescaline [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12433-9","Bufotenine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12296-0","Mescaline [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12295-2","Hallucinogens [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12292-9","Dimethyltryptamine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99257-5","Oxycodone+Oxymorphone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99251-8","Oxycodone+Oxymorphone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99229-4","Tapentadol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99227-8","Meperidine+Normeperidine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99226-0","Fentanyl+Norfentanyl | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99218-7","Tapentadol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP99216-1","Fentanyl+Norfentanyl","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP97410-2","Codeine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP97406-0","6-Monoacetylmorphine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69828-9","Dihydrocodeine Free+Hydrocodol Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69790-1","Dihydrocodeine Free+Hydrocodol Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69785-1","Methadone+metabolite | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69751-3","Methadone+metabolite | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69721-6","Buprenorphine+Norbuprenorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69618-4","Dihydrocodeine+hydrocodeinone | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69611-9","Dihydrocodeine+hydrocodeinone | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69363-7","Propoxyphene+acetaminophen | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP67150-0","Meperidine+Normeperidine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP66955-3","Meperidine+Normeperidine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP66670-8","Codeine Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP66669-0","Hydrocodone Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP66372-1","Dihydrocodeine+hydrocodol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP64885-4","Normorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP64884-7","Norcodeine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP64883-9","Norcodeine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP64857-3","Norcodeine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP63572-9","Norpropoxyphene | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP63009-2","Morphine-3-glucuronide | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP62452-5","Morphine-6-glucuronide | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP57465-4","6-monoacetylmorphine Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP57120-5","Oxymorphone Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP57119-7","Oxycodone Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP57118-9","Hydromorphone Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP55150-4","Nalbuphine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP55136-3","Propoxyphene | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP55021-7","Morphine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54999-5","Sufentanil | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54970-6","Butorphanol | Body Fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54821-1","Opiates | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54818-7","Opiates | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP53508-5","Oxymorphone Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP53507-7","Dihydrocodeine+hydrocodol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52861-9","Propoxyphene | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52507-8","Naloxone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52339-6","2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52338-8","2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52337-0","2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52057-4","Opiates | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52038-4","Trimeperidine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52008-7","Hydrocodone | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP52006-1","Codeine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51894-1","Morphine | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51891-7","Hydromorphone | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51750-5","Opiates | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51526-9","Nicomorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51491-6","Nalorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51307-4","Levorphanol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51287-8","Hydromorphone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51286-0","Hydrocodone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51204-3","Dipipanone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51145-8","Meperidine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP51027-8","Dextromoramide | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50718-3","Methadone.R | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50660-7","Opiates | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50446-1","Anileridine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50444-6","Anileridine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50429-7","Methadone.long Acting Metabolite | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50287-9","Alphaprodine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50286-1","Alfentanil | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49866-4","Oxycodone | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49865-6","Morphine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49863-1","6-monoacetylmorphine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49856-5","Meperidine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49849-0","Hydromorphone | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49848-2","Hydrocodone | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49728-6","Alphaprodine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49594-2","Narcotics and opioids | Bile fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49592-6","Morphine Free | Bile fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49590-0","Methadone | Bile fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49116-4","Methadone | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49090-1","Norpropoxyphene | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49084-4","Narcotics and opioids | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49083-6","Narcotics and opioids | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49079-4","Fentanyl | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49075-2","6-monoacetylmorphine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49069-5","Morphine Free | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP49053-9","Methadone | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48885-5","Naloxone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48819-4","Normeperidine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48745-1","Hydrocodone Free | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48730-3","Opiates | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48729-5","Hydromorphone Free | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48728-7","Hydrocodone Free | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48727-9","Codeine Free | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48716-2","Oxycodone Free | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48693-3","Norpropoxyphene | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48691-7","Methadone | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48690-9","Morphine Free | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48685-9","Hydromorphone Free | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48679-2","Propoxyphene | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48654-5","Opiates | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48618-0","Morphine Free | Cerebral spinal fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48617-2","Morphine | Cerebral spinal fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48616-4","Methadone | Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48611-5","Norpropoxyphene | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48604-0","Norpropoxyphene | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48517-4","Oxycodone | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48515-8","Hydrocodone | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48514-1","Hydromorphone | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48465-6","Opiates | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48454-0","Oxycodone | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48453-2","6-monoacetylmorphine | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48452-4","Codeine | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48451-6","Hydrocodone | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48450-8","Hydromorphone | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48439-1","Morphine Free | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46219-9","Morphine Free | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45844-5","Sufentanil | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45379-2","Opiates | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45375-0","Norpropoxyphene | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45312-3","Methylfentanyl | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45299-2","Methadone.long Acting Metabolite | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45076-4","Hydromorphone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP45007-9","Ethylmorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44947-7","Nalbuphine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44928-7","Fentanyl | Body Fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44907-1","Diamorphine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44903-0","Propoxyphene | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44902-2","Dextromoramide | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44778-6","Buprenorphine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44701-8","Alfentanil | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44659-8","6-monoacetylmorphine Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44645-7","Nalbuphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44640-8","Levorphanol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44636-6","Buprenorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44632-5","Propoxyphene | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44631-7","Methadone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44630-9","Diamorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44033-6","Morphine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP44031-0","Codeine | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43870-2","Morphine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43867-8","Methadone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43864-5","Codeine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43695-3","Oxycodone | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43682-1","6-monoacetylmorphine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43671-4","Meperidine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43525-2","Meperidine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43093-1","Dihydrocodeine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP43092-3","Dihydrocodeine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42798-6","Morphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42793-7","Codeine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42175-7","Oxycodone Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42174-0","6-monoacetylmorphine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42173-2","Hydromorphone Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42172-4","Hydrocodone Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42171-6","Dihydrocodeine Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42170-8","Codeine Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42082-5","Narcotics and opioids | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42078-3","Papaverine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41958-7","6-beta naltrexone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41946-2","Butorphanol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41908-2","Propoxyphene | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41907-4","Methadone | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41905-8","Opiates | Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41890-2","Oxymorphone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41880-3","Butorphanol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41872-0","Diamorphine | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41856-3","Naltrexone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41855-5","Hydrocodone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41770-6","Codeine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41752-4","Oxycodone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41494-3","Oxymorphone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41492-7","Morphine Free | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41491-9","Methadone | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41482-8","Fentanyl | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41481-0","Propoxyphene | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41320-0","Norfentanyl | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41319-2","Norfentanyl | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41318-4","Despropionylfentanyl | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41317-6","Despropionylfentanyl | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41268-1","Propoxyphene | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41266-5","Methadone | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41242-6","Oxycodone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41240-0","Naltrexone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41228-5","6-monoacetylmorphine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP40868-9","Normeperidine | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP40657-6","Opiates | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP40628-7","Norpropoxyphene | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP40489-4","Dihydrocodeine Free+Hydrocodol Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP40336-7","Dihydrocodeine+Hydrocodol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP40335-9","Oxymorphone Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP36029-4","Methadone+Metabolite","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP35885-0","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP31478-8","Narcotic antagonists","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP29091-3","Oxycodone Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP29067-3","Hydromorphone Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP29064-0","Hydrocodone Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP29031-9","Codeine Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP28863-6","Morphine Free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP28812-3","6-monoacetylmorphine free","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP28525-1","Naloxone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP21164-6","Dihydrocodeine+Hydrocodeinone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP19141-8","Methadone.long acting metabolite","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP182210-7","Acetyl fentanyl | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18183-1","Dihydrocodeine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18149-2","Narcotics and opioids","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18145-0","Papaverine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP18094-0","6-Beta naltrexone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180841-1","Meperidine | Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180693-6","Hydromorphone | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP180382-6","Morphine | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP179843-0","Meperidine | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP17947-0","Propoxyphene + Norpropoxyphene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP17874-6","Sufentanil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP17844-9","Butorphanol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP178270-7","Fentanyl | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP172593-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP163963-4","Mitragynine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP163962-6","7-Hydroxymitragynine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16300-3","Trimeperidine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16217-9","Nicomorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16213-8","Nalorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16212-0","Nalbuphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16184-1","Meperidine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16173-4","Levorphanol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16162-7","Hydromorphone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16161-9","Hydrocodone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16139-5","Ethylmorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16117-1","Dipipanone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16107-2","Diamorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16106-4","Dextromoramide","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16093-4","Codeine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16054-6","Buprenorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16036-3","Anileridine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16022-3","Alphaprodine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16021-5","Alfentanil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158126-5","6-Beta naltrexone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158122-4","Oxymorphone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158120-8","Buprenorphine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158118-2","Fentanyl | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158115-8","Hydrocodone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158114-1","Morphine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158113-3","Meperidine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158109-1","Norfentanyl | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158108-3","Norhydrocodone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158107-5","Normeperidine | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158106-7","Noroxycodone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP158102-6","Hydromorphone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157972-3","Norpropoxyphene | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157971-5","Propoxyphene + Norpropoxyphene | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157970-7","Propoxyphene | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157938-4","Propoxyphene + Norpropoxyphene | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157928-5","Propoxyphene + Norpropoxyphene | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157686-9","Mitragynine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157661-2","Methadone+Metabolite | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157595-2","Methadone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP157594-5","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15176-8","Oxymorphone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15174-3","Morphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15167-7","Fentanyl","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15048-9","Norfentanyl","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15047-1","Despropionylfentanyl","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15017-4","Propoxyphene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15015-8","Methadone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15003-4","Oxycodone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP15000-0","Naltrexone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14980-4","6-Monoacetylmorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP149566-4","Oxycodone+Oxymorphone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14726-1","Normeperidine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14710-5","Propoxyphene+Acetaminophen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14565-3","Opiates","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14549-7","Norpropoxyphene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP136076-9","Oxycodone | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP135764-1","Oxymorphone | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP133002-8","Tapentadol | Tissue and Smears","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP124893-1","Fentanyl+Norfentanyl | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP121247-3","Nortapentadol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102617-0","Norhydrocodone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102616-2","Noroxycodone | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102596-6","Norhydrocodone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102595-8","Noroxycodone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102277-3","Normeperidine | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102276-5","Norfentanyl | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102269-0","Fentanyl | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102268-2","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102258-3","Normeperidine | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102257-5","Norfentanyl | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP102252-6","Fentanyl | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP101457-2","6-Acetylcodeine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP101086-9","Papaverine | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100154-6","Tapentadol | Body fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","LP100153-8","Tapentadol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","9835-0","Hydromorphone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8223-0","Opiates [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","8218-0","Opiates [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","795226","Trimeperidine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","794922","Trimeperidine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","794617","Trimeperidine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74383-1","Fentanyl [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74380-7","Hydromorphone [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74379-9","Morphine [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74378-1","Meperidine [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74372-4","Acetyl fentanyl [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74167-8","Opiates [Mass/volume] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74137-1","Norfentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74136-3","Fentanyl [Mass/volume] in Serum, Plasma or Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74131-4","Morphine [Mass/volume] in Serum, Plasma or Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74130-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum, Plasma or Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","74108-2","Meperidine [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73996-1","Oxycodone [Presence] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73995-3","Mitragynine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73972-2","Morphine Free [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73942-5","Buprenorphine [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73941-7","6-monoacetylmorphine free [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73940-9","Hydromorphone Free [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73939-1","Hydrocodone Free [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73938-3","Fentanyl [Mass/volume] in Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73937-5","Norfentanyl [Mass/volume] in Blood by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73936-7","Fentanyl [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73934-2","Meperidine [Mass/volume] in Serum, Plasma or Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73933-4","Normeperidine [Mass/volume] in Serum, Plasma or Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73753-6","Oxycodone [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73729-6","Meperidine [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73727-0","Methadone [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73567-0","Propoxyphene [Presence] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","73562-1","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","728051","Oxycodone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72789-1","Naltrexone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72788-3","6-Beta naltrexone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72787-5","6-Beta naltrexone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72766-9","Oxymorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72763-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72762-8","Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72760-2","Fentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72759-4","Codeine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72753-7","Hydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72752-9","Morphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72751-1","Oxycodone [Mass/volume] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72750-3","Oxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72749-5","Meperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72745-3","Norfentanyl [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72744-6","Norhydrocodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72743-8","Normeperidine [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72742-0","Noroxycodone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72734-7","Methadone [Mass/volume] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72733-9","Hydromorphone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72732-1","Mitragynine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72731-3","7-Hydroxymitragynine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72730-5","Mitragynine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72729-7","7-Hydroxymitragynine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72626-5","Methadone [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72622-4","Propoxyphene [Presence] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72621-6","Propoxyphene [Mass/volume] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72620-8","Norpropoxyphene [Presence] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72619-0","Norpropoxyphene [Mass/volume] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72618-2","Propoxyphene + Norpropoxyphene [Presence] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72617-4","Propoxyphene [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72485-6","Tapentadol [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72475-7","Methadone+Metabolite [Presence] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72402-1","Oxycodone [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72401-3","Propoxyphene [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72400-5","Methadone [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72388-2","Methadone [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72387-4","Methadone [Presence] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72386-6","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72385-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Saliva (oral fluid) by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","72384-1","Meperidine+Normeperidine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","722907","Opiates [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","722603","Opiates [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","719895","Norpropoxyphene [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","719589","Norpropoxyphene [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","719285","Normeperidine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","71430-3","Oxycodone+Oxymorphone [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","712649","Nicomorphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","709334","Nalorphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","709028","Nalbuphine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","708724","Nalbuphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","708419","Nalbuphine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","705710","Morphine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","705405","Morphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","705101","Morphine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","704798","Morphine Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","704189","Morphine Free [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","703883","Morphine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","703579","Morphine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70215-9","Oxycodone [Moles/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70210-0","Morphine [Moles/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70206-8","Codeine [Moles/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70197-9","6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70151-6","Opiates [Presence] in Urine by Screen method >300 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70150-8","Opiates [Mass/volume] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70149-0","Methadone [Presence] in Urine by Screen method >300 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70148-2","Methadone [Presence] in Urine by Screen method >150 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","70147-4","Methadone [Mass/volume] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69356-4","Oxycodone [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69028-9","Oxymorphone [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","69027-1","Morphine [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","68544-6","Hydrocodone [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","68543-8","Oxycodone [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","68542-0","Codeine [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","68541-2","Hydromorphone [Mass/mass] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","684922","Methadone [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","684648","Methadone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","684345","Methadone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","683736","Methadone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","683430","Methadone [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","674970","Meperidine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","674664","Meperidine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","674360","Meperidine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","674056","Meperidine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","662307","Levorphanol [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","662003","Levorphanol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","661699","Levorphanol [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","66130-6","Fentanyl+Norfentanyl [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","66129-8","Fentanyl+Norfentanyl [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","661091","Levorphanol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","65808-8","Nortapentadol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","65807-0","Tapentadol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","650896","Hydromorphone [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","650590","Hydrocodone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","650286","Hydrocodone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","649981","Hydrocodone [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","64131-6","Dihydrocodeine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","634580","Fentanyl [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","634276","Fentanyl [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","627944","Ethylmorphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","627640","Ethylmorphine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61429-7","Tapentadol/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61425-5","Noroxycodone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61424-8","Noroxycodone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61423-0","Noroxycodone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61422-2","Norhydrocodone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61421-4","Norhydrocodone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61420-6","Norhydrocodone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","611995","Dipipanone [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61197-0","Oxycodone+Oxymorphone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","611418","Dipipanone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","611112","Dipipanone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61087-3","Normeperidine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61086-5","Norfentanyl [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61077-4","Fentanyl [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61076-6","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61054-3","Normeperidine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61053-5","Norfentanyl [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61052-7","Norfentanyl [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","61042-8","Fentanyl [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60514-7","6-Acetylcodeine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60467-8","Oxymorphone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60330-8","Propoxyphene [Moles/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60276-3","Oxycodone+Oxymorphone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","601737","Diamorphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","601434","Diamorphine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60126-0","Papaverine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60125-2","Papaverine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","600826","Propoxyphene [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","60071-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","600246","Propoxyphene [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","599942","Propoxyphene [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59961-3","Propoxyphene [Moles/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59960-5","Propoxyphene [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59944-9","Normeperidine [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59924-1","Meperidine [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","599030","Dextromoramide [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59734-4","Propoxyphene [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59705-4","Methadone [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59673-4","Fentanyl [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59355-8","Tapentadol [Mass/volume] in Tissue","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59354-1","Tapentadol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59353-3","Tapentadol [Mass/volume] in Body fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","59352-5","Tapentadol [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","587555","Codeine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","586946","Codeine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","586640","Codeine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","586336","Codeine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58430-0","Oxycodone+Oxymorphone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58429-2","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58428-4","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58402-9","Tapentadol [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58401-1","Tapentadol [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58399-7","Norpropoxyphene/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58398-9","Propoxyphene/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58396-3","Oxymorphone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58395-5","Oxycodone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58394-8","Hydromorphone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58393-0","Hydrocodone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58392-2","Morphine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58391-4","Codeine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58390-6","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58389-8","Normeperidine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58388-0","Normeperidine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58387-2","Normeperidine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58386-4","Meperidine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58385-6","Meperidine+Normeperidine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58384-9","6-Monoacetylmorphine (6-MAM)/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58383-1","Norfentanyl [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58382-3","Norfentanyl/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58381-5","Fentanyl [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58380-7","Fentanyl/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58379-9","Fentanyl+Norfentanyl [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58360-9","Buprenorphine/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","58359-1","Buprenorphine+Norbuprenorphine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57982-1","Hydromorphone [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57981-3","Hydrocodone [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57865-8","Oxycodone [Moles/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57864-1","Meperidine [Moles/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57863-3","Hydromorphone [Moles/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57861-7","Hydrocodone [Moles/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57304-8","Codeine [Mass/volume] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","57300-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55574-8","Propoxyphene + Norpropoxyphene [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55559-9","Norpropoxyphene [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55537-5","Fentanyl [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55523-5","Anileridine [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","55520-1","6-Monoacetylmorphine (6-MAM) [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","553830","Buprenorphine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","553525","Buprenorphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","552645","Buprenorphine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","53846-2","Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","533072","Anileridine [Moles/volume] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","532161","Anileridine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","531855","Anileridine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","52958-6","Methadone [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","52952-9","Opiates [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51984-3","Meperidine+Normeperidine [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51955-3","Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51954-6","Oxycodone Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51765-6","Dihydrocodeine+Hydrocodol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51740-9","6-monoacetylmorphine free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51739-1","Codeine Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51738-3","Hydrocodone Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51737-5","Hydromorphone Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51736-7","Oxymorphone Free [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51691-4","Opiates [Presence] in Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","515571","Alphaprodine [Mass/time] in 24 hour Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","514660","Alphaprodine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","51448-9","Dihydrocodeine+Hydrocodol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","514354","Alphaprodine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","514049","Alfentanil [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","50620-4","Opiates cutoff [Mass/mass] in Meconium for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","50542-0","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","50021-5","Oxycodone [Mass/volume] in Serum, Plasma or Blood by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49831-1","Normorphine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49830-3","Norcodeine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49829-5","Norcodeine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49752-9","Buprenorphine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49750-3","Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","49749-5","6-monoacetylmorphine free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48964-1","Propoxyphene [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48963-3","Propoxyphene [Mass/volume] in Unspecified specimen by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48961-7","Opiates [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48960-9","Norpropoxyphene [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48957-5","Methadone [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48956-7","Methadone [Mass/volume] in Unspecified specimen by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48403-0","Methadone+Metabolite [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48365-1","Methadone.R [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48364-4","Morphine-3-Glucuronide [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","48363-6","Morphine-6-Glucuronide [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","47415-5","Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","47411-4","Methadone [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","47004-7","6-monoacetylmorphine free [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46975-9","Oxymorphone Free [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46974-2","Oxymorphone Free [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46973-4","Oxycodone Free [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46971-8","Hydromorphone Free [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46704-3","Dihydrocodeine Free+Hydrocodol Free [Mass/volume] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46703-5","Dihydrocodeine Free+Hydrocodol Free [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46263-0","6-monoacetylmorphine free [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46262-2","Codeine Free [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46261-4","Hydrocodone Free [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46260-6","Hydromorphone Free [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46259-8","Morphine Free [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46258-0","Oxymorphone Free [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46257-2","Dihydrocodeine+Hydrocodol [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","46256-4","Oxycodone Free [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","45022-1","Methadone+Metabolite [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43811-9","Propoxyphene [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43595-8","Methadone [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43200-5","Norfentanyl [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43199-9","Norfentanyl [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","43184-1","6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42901-9","Dihydrocodeine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42618-9","Naloxone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","42251-9","Methadone+Metabolite [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41860-8","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41859-0","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41858-2","2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41466-4","Methadone/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41465-6","Opiates/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","41038-1","Codeine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40839-3","Fentanyl [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40806-2","Opiates [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40805-4","Opiates [Presence] in Hair by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40634-8","Hydrocodone [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40626-4","Codeine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40528-2","Opiates [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40384-0","Morphine [Presence] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","40369-1","Hydromorphone [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","38373-7","Buprenorphine+Norbuprenorphine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3744-0","Meperidine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3683-0","Hydromorphone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","35649-3","Propoxyphene [Mass/volume] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","35626-1","Norpropoxyphene [Mass/volume] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","35625-3","Normeperidine [Mass/volume] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","35618-8","Methadone [Mass/volume] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","35617-0","Meperidine [Mass/volume] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3541-0","Dextromoramide [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","34427-5","Methadone.R [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","34177-6","Opiates [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3414-0","Buprenorphine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","33527-3","Methadone.long acting metabolite [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","3310-0","Alphaprodine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32125-7","Propoxyphene [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32101-8","Oxycodone [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32100-0","Morphine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32099-4","6-Monoacetylmorphine (6-MAM) [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32093-7","Methadone [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32088-7","Meperidine [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32081-2","Hydromorphone [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","32080-4","Hydrocodone [Presence] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31088-8","Narcotics and opioids [Identifier] in Bile fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31086-2","Morphine Free [Mass/volume] in Bile fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","31084-7","Methadone [Mass/volume] in Bile fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29400-9","Meperidine [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29387-8","Norpropoxyphene [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29377-9","Narcotics and opioids [Identifier] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29376-1","Narcotics and opioids [Identifier] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29372-0","Codeine [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29356-3","Fentanyl [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29345-6","6-Monoacetylmorphine (6-MAM) [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29337-3","Morphine Free [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29294-6","Methadone [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29287-0","Morphine [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29285-4","Methadone [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29278-9","Codeine [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29159-1","Methadone [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","29158-3","Opiates [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2897895","Hydromorphone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2888825","Propoxyphene [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2877108","Nalbuphine [Mass/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2862620","Propoxyphene [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2821925","Propoxyphene + Norpropoxyphene [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","28072-7","Dihydrocodeine+Hydrocodeinone [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","28061-0","Naloxone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27920-8","Normeperidine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2753259","Morphine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2737920","Sufentanil [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2737615","Sufentanil [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27357-3","Hydrocodone Free [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27321-9","Opiates [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27314-4","Hydromorphone Free [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27312-8","Hydrocodone Free [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27311-0","Codeine Free [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27293-0","Oxycodone Free [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27283-1","Methadone [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27281-5","Propoxyphene [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27211-2","Norpropoxyphene [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27207-0","Methadone [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27206-2","Morphine Free [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27196-5","Hydromorphone Free [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27190-8","Propoxyphene [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27136-1","Opiates [Presence] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2707757","Butorphanol [Mass/volume] in Body fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27067-8","Propoxyphene [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27064-5","Opiates [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27054-6","Morphine Free [Mass/volume] in Cerebral spinal fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27053-8","Morphine [Mass/volume] in Cerebral spinal fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27052-0","Methadone [Mass/volume] in Milk","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27041-3","Norpropoxyphene [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27035-5","Dihydrocodeine+Hydrocodeinone [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","27029-8","Norpropoxyphene [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26869-8","Oxycodone [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26865-6","Codeine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26863-1","Hydrocodone [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26862-3","Hydromorphone [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26860-7","Morphine [Mass/mass] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26744-3","Opiates [Mass/mass] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26722-9","Oxycodone [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26721-1","6-Monoacetylmorphine (6-MAM) [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26720-3","Codeine [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26719-5","Hydrocodone [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26718-7","Hydromorphone [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","26696-5","Morphine Free [Mass/mass] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2310585","Opiates [Presence] in Unknown substance by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2310281","Opiates [Presence] in Unknown substance by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2310008","Opiates [Presence] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2309096","Opiates [Presence] in Urine by SAMHSA screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2308790","Opiates [Presence] in Urine by SAMHSA confirm method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2308486","Opiates [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2308181","Opiates [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2307270","Opiates [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2306964","Opiates [Presence] in Meconium by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2306659","Opiates [Presence] in Meconium by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2306386","Opiates [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2305778","Opiates [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2305472","Opiates [Presence] in Gastric fluid by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2305167","Opiates [Presence] in Gastric fluid by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2304863","Opiates [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","2304560","Opiates [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","21431-2","Opiates [Presence] in Urine by Screen method >2000 ng/mL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20551-8","Nalbuphine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20550-0","Morphine Free [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20540-1","Levorphanol [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","20527-8","Ethylmorphine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19650-1","Oxymorphone cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19649-3","Oxymorphone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19648-5","Oxymorphone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19646-9","Oxymorphone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19645-1","Oxycodone cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19644-4","Oxycodone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19643-6","Oxycodone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19642-8","Oxycodone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19637-8","Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19636-0","Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19635-2","Norpropoxyphene [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19632-9","Norpropoxyphene [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19613-9","Naltrexone cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19612-1","Naltrexone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19611-3","Naltrexone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19610-5","Naltrexone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19609-7","Naltrexone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19608-9","Nalbuphine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19607-1","Nalbuphine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19605-5","Nalbuphine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19604-8","Morphine Free cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19603-0","Morphine Free cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19602-2","Morphine Free [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19601-4","Morphine Free [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19600-6","Morphine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19599-0","Morphine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19597-4","Morphine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19593-3","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19553-7","Methadone cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19552-9","Methadone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19550-3","Methadone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19535-4","Meperidine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19534-7","Meperidine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19532-1","Meperidine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19519-8","Levorphanol cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19518-0","Levorphanol cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19516-4","Levorphanol [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19488-6","Hydromorphone cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19487-8","Hydromorphone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19486-0","Hydromorphone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19485-2","Hydrocodone cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19484-5","Hydrocodone cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19483-7","Hydrocodone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19482-9","Hydrocodone [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19465-4","Ethylmorphine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19464-7","Ethylmorphine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19463-9","Ethylmorphine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19462-1","Ethylmorphine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19451-4","Dihydrocodeine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19450-6","Dihydrocodeine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19449-8","Dihydrocodeine [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19448-0","Dihydrocodeine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19446-4","Dihydrocodeine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19442-3","Diamorphine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19441-5","Diamorphine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19439-9","Diamorphine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19438-1","Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19437-3","Propoxyphene + Norpropoxyphene cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19436-5","Propoxyphene + Norpropoxyphene [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19435-7","Propoxyphene + Norpropoxyphene [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19434-0","Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19433-2","Propoxyphene + Norpropoxyphene [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19432-4","Propoxyphene cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19431-6","Propoxyphene cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19429-0","Propoxyphene [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19414-2","Codeine cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19413-4","Codeine cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19411-8","Codeine [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19380-5","Butorphanol cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19379-7","Butorphanol cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19378-9","Butorphanol [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19377-1","Butorphanol [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19324-3","6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19323-5","6-Monoacetylmorphine (6-MAM) cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19322-7","6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19321-9","6-Monoacetylmorphine (6-MAM) [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19302-9","Opiates confirm method [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19301-1","Opiates screen method [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19300-3","Opiates cutoff [Mass/volume] in Urine for Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19299-7","Opiates cutoff [Mass/volume] in Urine for Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19297-1","Opiates tested for in Urine by Screen method Narrative","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19296-3","Opiates tested for in Urine by Screen method Nominal","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19295-5","Opiates [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19141-1","Propoxyphene [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","19138-7","Opiates cutoff [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18473-9","Hydromorphone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18435-8","Sufentanil [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18390-5","Opiates [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18387-1","Diamorphine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18383-0","Alfentanil [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18343-4","6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18334-3","Naltrexone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","18325-1","Oxymorphone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17395-5","Oxymorphone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17384-9","Opiates [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17377-3","Norpropoxyphene [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17376-5","Norpropoxyphene [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17318-7","Nalbuphine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17290-8","Morphine [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17275-9","Methylfentanyl [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","17259-3","Methadone.long acting metabolite [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16998-7","Hydromorphone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16858-3","Fentanyl [Mass/volume] in Body fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16775-9","Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16756-9","Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16755-1","Diamorphine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16754-4","Diamorphine [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16748-6","Propoxyphene [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16747-8","Dextromoramide [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16644-7","Codeine Free [Presence] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16499-6","Butorphanol [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16334-5","Alfentanil [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16253-7","Meperidine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16252-9","Hydrocodone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16251-1","Morphine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16250-3","Codeine [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16249-5","Oxycodone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16248-7","6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16246-1","Methadone [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16242-0","Propoxyphene [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16218-0","Nalbuphine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16213-1","Levorphanol [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16211-5","Dihydrocodeine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16208-1","Buprenorphine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16207-3","Meperidine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16200-8","Propoxyphene [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16199-2","Methadone [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16198-4","Diamorphine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16197-6","Codeine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","16196-8","Morphine [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15370-0","Morphine [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15364-3","Codeine [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15110-0","Morphine [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15108-4","Methadone [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","15102-7","Codeine [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14863-5","Oxycodone [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14844-5","6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14843-7","6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14826-2","Meperidine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14261-2","Codeine [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14067-3","Dihydrocodeine [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","14066-5","Dihydrocodeine [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","1390296","Opiates [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","13648-1","Morphine [Presence] in Urine by SAMHSA confirm method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","13641-6","Codeine [Presence] in Urine by SAMHSA confirm method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","13576-4","Oxycodone [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12789-4","Oxycodone Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12788-6","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12787-8","Hydromorphone Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12786-0","Hydrocodone Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12785-2","Dihydrocodeine Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12784-5","Codeine Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12554-2","Narcotics and opioids [Identifier] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12550-0","Papaverine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12407-3","6-Beta naltrexone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12395-0","Butorphanol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12394-3","Butorphanol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12357-0","Propoxyphene [Presence] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12356-2","Methadone [Presence] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12354-7","Opiates [Presence] in Stool","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12342-2","Oxymorphone [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12333-1","Butorphanol [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12326-5","Diamorphine [Presence] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12309-1","Naltrexone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","12308-3","Hydrocodone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11247-4","Oxymorphone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11246-6","Oxycodone [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11244-1","Morphine Free [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11243-3","Methadone [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11235-9","Fentanyl [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11234-2","Propoxyphene [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11075-9","Norfentanyl [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11074-2","Norfentanyl [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11073-4","Despropionylfentanyl [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11072-6","Despropionylfentanyl [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11027-0","Propoxyphene [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","11025-4","Methadone [Mass/volume] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10998-3","Oxycodone [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10996-7","Normeperidine [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10994-2","Naltrexone [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10976-9","6-Monoacetylmorphine (6-MAM) [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10975-1","6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10544-5","Normeperidine [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10533-8","Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10369-7","Opiates [Mass/mass] in Hair","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.1","LOINC","10341-6","Norpropoxyphene [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP98071-1","HIV 2 p34 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP98070-3","HIV 2 p16 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP98069-5","HIV 2 gp140 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP96479-8","HIV 1+2 Ab+HIV1 p24 Ag | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP69787-7","HIV 2 p31+p34 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP64382-2","HIV Identified | Semen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP62411-1","HIV 1+O+2 Ab","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP57525-5","HIV 2 gp120 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP57485-2","HIV 2 Ab | Cerebral spinal fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP55190-0","HIV DNA | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54308-9","HIV Identified | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP54306-3","HIV Identified | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50859-5","HIV 2 proviral DNA | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP50555-9","HIV 2 IgG | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48996-0","HIV 2 | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48210-6","HIV 2 DNA | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP48209-8","HIV 2 DNA | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP47065-5","HIV 2 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46843-6","HIV 2 p58 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46842-8","HIV 2 p55 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46841-0","HIV 2 p31 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46840-2","HIV 2 gp34 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46838-6","HIV 2 gp15 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP46836-0","HIV 2 gp105 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP42995-8","HIV 2 p41 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41328-3","HIV 2 p68 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41327-5","HIV 2 p56 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41326-7","HIV 2 p53 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41324-2","HIV 2 p26 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41323-4","HIV 2 gp80 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41151-9","HIV 2 gp36 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP41150-1","HIV 2 gp125 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP38465-8","HIV 2 DNA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP38463-3","HIV 2 Ab","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP38459-1","HIV 1+2 Ab","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP38420-3","HIV identified","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP36877-6","HIV nonnucleoside reverse transcriptase gene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP36876-8","HIV nucleoside reverse transcriptase gene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP36650-7","HIV 1 and 2","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP32723-6","HIV reverse transcriptase+protease gene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP30901-0","HIV protease gene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP29063-2","HIV reverse transcriptase gene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16716-0","HIV 2","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP16715-2","HIV 1+2","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP14307-0","HIV 1","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP136082-7","HIV 2 RNA | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP132439-3","HIV 1 and 2 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP132221-5","HIV 1 and 2 | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","LP111605-4","HIV 2 p15 Ab | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","9836-8","HIV DNA [Presence] in Blood by Probe with amplification","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","7919-4","HIV 2 Ab [Presence] in Serum","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","69668-2","HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","69354-9","HIV 2 RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","69353-1","HIV 2 RNA [Presence] in Serum or Plasma by Probe and target amplification method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","6431-1","HIV identified in Unspecified specimen by Organism specific culture","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","6430-3","HIV identified in Semen by Organism specific culture","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","6429-5","HIV identified in Blood by Organism specific culture","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","62456-9","HIV 2 p15 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","58900-2","HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum by Immunoassay","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","57978-9","HIV 2 p34 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","57977-1","HIV 2 p16 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","57976-3","HIV 2 gp140 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","56888-1","HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum by Immunoassay","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","5225-8","HIV 2 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","5224-1","HIV 2 Ab [Units/volume] in Serum by Immunoassay","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","51786-2","HIV 2 Ab Signal/Cutoff in Serum by Immunoassay","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","47029-4","HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","45212-8","HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","43185-8","HIV 1 and 2 Ab band pattern [interpretation] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","42768-2","HIV 1 and 2 Ab [interpretation] in Serum Narrative","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","34699-9","HIV 2 proviral DNA [Presence] in Serum or Plasma by Probe and target amplification method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","33807-9","HIV 2 IgG Ab [Presence] in Serum","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","33806-1","HIV 2 IgG Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","31073-0","HIV 2 Ab band pattern [interpretation] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","30361-0","HIV 2 Ab [Presence] in Serum by Immunoassay","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","25842-6","HIV 2 DNA [Presence] in Unspecified specimen by Probe and target amplification method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","25841-8","HIV 2 DNA [Presence] in Blood by Probe and target amplification method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","22358-6","HIV 2 Ab [Units/volume] in Serum","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21340-5","HIV 2 p58 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21339-7","HIV 2 p55 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21338-9","HIV 2 p31 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21337-1","HIV 2 gp34 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21336-3","HIV 2 gp15 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21335-5","HIV 2 gp120 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","21334-8","HIV 2 gp105 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","13920-4","HIV 2 p41 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","11082-5","HIV 2 p68 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","11081-7","HIV 2 p56 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","11080-9","HIV 2 p53 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","11079-1","HIV 2 p26 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","11078-3","HIV 2 gp80 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","10902-5","HIV 2 gp36 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.1","LOINC","10901-7","HIV 2 gp125 Ab [Presence] in Serum by Immunoblot (IB)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP54131-5","Ethanol | Exhaled gas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP53374-2","Ethyl glucuronide | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP51222-5","Disulfiram | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP50880-1","Ethanol | Saliva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP49842-5","Ethanol | XXX","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP47217-2","Ethanol | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP45002-0","Ethanol | Body Fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP45001-2","Ethanol | Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP44964-2","Disulfiram | Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP44049-2","Ethanol | Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP43273-9","Ethanol | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP42011-4","Ethanol | Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP40656-8","Ethanol | Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP172697-7","Ethanol+Methanol+Isopropyl alchohol+Acetone | Bld-Ser-Plas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP16119-7","Disulfiram","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP14348-4","Ethanol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","LP131065-7","Ethanol | Tissue and Smears","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","9357-5","Disulfiram [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","61095-6","Ethanol [Presence] in Gastric fluid by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","61066-7","Ethanol [Presence] in Unspecified specimen by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","58378-1","Ethyl glucuronide [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","58377-3","Ethyl glucuronide [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","58376-5","Ethyl glucuronide/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","58375-7","Ethyl glucuronide [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","58356-7","Ethanol/Creatinine [Mass Ratio] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","56478-1","Ethanol [Mass/volume] in Blood by Gas chromatography","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5645-7","Ethanol [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5644-0","Ethanol [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5643-2","Ethanol [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5642-4","Ethanol [Presence] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5641-6","Ethanol [Mass/volume] in Exhaled gas","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5640-8","Ethanol [Mass/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","5639-0","Ethanol [Presence] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","55349-5","Ethyl glucuronide [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","50343-3","Ethanol [Presence] in Saliva (oral fluid) by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","50022-3","Ethanol+Methanol+Isopropyl alchohol+Acetone [Presence] in Serum, Plasma or Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","48342-0","Ethanol+Methanol+Isopropyl alchohol+Acetone [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","47107-8","Ethanol [Moles/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","46983-3","Ethanol [Mass/volume] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","45324-1","Ethyl glucuronide [Mass/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","42242-8","Ethanol [Presence] in Urine by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","40530-8","Ethanol [Presence] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","3577-4","Disulfiram [Mass/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","35664-2","Ethanol [Mass/volume] in unspecified time Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","34882-1","Ethanol [Mass/volume] in Saliva (oral fluid)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","34180-0","Ethanol [Presence] in Urine by Confirmatory method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","32070-5","Ethanol [Moles/volume] in Unspecified specimen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","23861-8","Ethanol [Mass/mass] in Tissue","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","22745-4","Ethanol [Moles/volume] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","20470-1","Ethanol [Presence] in Serum or Plasma by Screen method","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","16843-5","Ethanol [Mass/volume] in Body fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","16842-7","Ethanol [Mass/volume] in Unknown substance","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","16781-7","Disulfiram [Presence] in Urine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","15402-1","Ethanol [Presence] in Meconium","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","15120-9","Ethanol [Moles/volume] in Blood","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","14719-9","Ethanol [Moles/volume] in Serum or Plasma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","14336-2","Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","12465-1","Ethanol [Mass/volume] in Vitreous fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.1","LOINC","10367-1","Ethanol [Mass/volume] in Gastric fluid","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","991149","Methadose 0.333 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","991147","Methadone Hydrochloride 0.333 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","967897","Campral Dose Pak","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","967896","{180 (Acamprosate calcium 333 MG Enteric Coated Tablet) } Pack","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904882","BuTrans 5 MCG/HR Weekly Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904880","168 HR Buprenorphine 0.005 MG/HR Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904878","BuTrans 20 MCG/HR Weekly Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904876","168 HR Buprenorphine 0.02 MG/HR Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904874","BuTrans 10 MCG/HR Weekly Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904871","BuTrans","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","904870","168 HR Buprenorphine 0.01 MG/HR Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","866331","Morphine / Naltrexone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864980","Methadose 0.333 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864978","Methadone Hydrochloride 0.333 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864769","Methadone Hydrochloride 2 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864761","Methadone Hydrochloride 1 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864737","Methadose 5 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864720","Dolophine 5 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864718","Methadone Hydrochloride 5 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864714","Methadone Hydrochloride 10 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864712","Methadose 10 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864708","Dolophine 10 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","864706","Methadone Hydrochloride 10 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863857","MS 80 MG / Naltrexone hydrochloride 3.2 MG Extended Release Capsule [Embeda]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863856","Morphine Sulfate 80 MG / Naltrexone hydrochloride 3.2 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863855","MS 60 MG / Naltrexone hydrochloride 2.4 MG Extended Release Capsule [Embeda]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863854","Morphine Sulfate 60 MG / Naltrexone hydrochloride 2.4 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863853","MS 50 MG / Naltrexone hydrochloride 2 MG Extended Release Capsule [Embeda]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863852","Morphine Sulfate 50 MG / Naltrexone hydrochloride 2 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863851","MS 30 MG / Naltrexone hydrochloride 1.2 MG Extended Release Capsule [Embeda]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863850","Morphine Sulfate 30 MG / Naltrexone hydrochloride 1.2 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863849","MS 20 MG / Naltrexone hydrochloride 0.8 MG Extended Release Capsule [Embeda]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863848","Morphine Sulfate 20 MG / Naltrexone hydrochloride 0.8 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863847","MS 100 MG / Naltrexone hydrochloride 4 MG Extended Release Capsule [Embeda]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","863845","Morphine Sulfate 100 MG / Naltrexone hydrochloride 4 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","859959","Embeda","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","835728","Campral 333 MG (equivalent to acamprosate 300 MG) Enteric Coated Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","835726","Acamprosate calcium 333 MG Enteric Coated Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","82819","acamprosate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","7243","Naltrexone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","6813","Methadone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","637216","Vivitrol 112 MG/ML Injectable Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","637213","Naltrexone 112 MG/ML Injectable Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","636556","Vivitrol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","602959","Campral","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","542214","Depade 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","542207","Depade","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","404414","Subutex 8 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","404413","Subutex 2 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","3554","Disulfiram","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","352990","Suboxone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","352364","Buprenorphine / Naloxone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","351267","Buprenorphine 8 MG / Naloxone 2 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","351266","Buprenorphine 2 MG / Naloxone 0.5 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","351265","Buprenorphine 8 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","351264","Buprenorphine 2 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","250426","buprenorphine (as buprenorphine hydrochloride) 0.4 MG Sublingual Tablet [250426]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","246474","Buprenorphine 0.2 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","238129","Buprenorphine 0.3 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","210716","Antabuse 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","210628","Antabuse 250 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","207028","ReVia 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","205533","Buprenex 0.3 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","203840","Buprenex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","202370","Dolophine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","199731","Disulfiram 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","198011","Naltrexone 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","197624","Disulfiram 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","197623","Disulfiram 250 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1819","Buprenorphine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1818","Subutex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","152751","Methadose","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","152092","ReVia","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1432971","BuTrans 15 MCG/HR Weekly Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1432969","168 HR Buprenorphine 0.015 MG/HR Transdermal Patch","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1431104","Zubsolv 5.7/1.4 Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1431102","Buprenorphine 5.7 MG / Naloxone 1.4 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1431083","Zubsolv 1.4/0.36 Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1431077","Zubsolv","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1431076","Buprenorphine 1.4 MG / Naloxone 0.36 MG Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1361710","1 ML Methadone Hydrochloride 1 MG/ML Prefilled Syringe","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1307063","Suboxone 12/3 Sublingual Film","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1307061","Buprenorphine 12 MG / Naloxone 3 MG Oral Strip","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1307058","Suboxone 4/1 Sublingual Film","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1307056","Buprenorphine 4 MG / Naloxone 1 MG Oral Strip","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","105069","Naltrexone hydrochloride","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1010609","Suboxone 8/2 Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1010608","Suboxone 2/0.5 Sublingual Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1010606","Suboxone 8/2 Sublingual Film","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1010604","Buprenorphine 8 MG / Naloxone 2 MG Oral Strip","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1010603","Suboxone 2/0.5 Sublingual Film","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.88","RxNorm","1010600","Buprenorphine 2 MG / Naloxone 0.5 MG Oral Strip","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","998426","Xerese (acyclovir 5 % / hydrocortisone 1 % ) Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","998425","Acyclovir / Hydrocortisone Topical Cream [Xerese]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","998424","Acyclovir 50 MG/ML / Hydrocortisone 10 MG/ML [Xerese]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","998423","Xerese","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","998422","Acyclovir 50 MG/ML / Hydrocortisone 10 MG/ML Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","998421","Acyclovir / Hydrocortisone Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","992413","Itraconazole 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","992412","Itraconazole 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","991219","Gammaplex 5 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","991218","Immunoglobulin G Injectable Solution [Gammaplex]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","991217","Immunoglobulin G, Human 50 MG/ML [Gammaplex]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","991216","Gammaplex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","970789","Buccal Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","9384","Rifampin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","92776","Gammar","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","92432","Fluconazole Injectable Solution [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","902753","Hizentra 20 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","902752","Immunoglobulin G Injectable Solution [Hizentra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","902751","Immunoglobulin G, Human 200 MG/ML [Hizentra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","902750","Hizentra","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","902749","Immunoglobulin G, Human 200 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","902748","Immunoglobulin G, Human 200 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","900577","Norvir 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","900576","Ritonavir Oral Tablet [Norvir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","900575","Ritonavir 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","900574","Ritonavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","876429","SMX 40 MG/ML / TMP 8 MG/ML Oral Suspension [Septra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","876428","Sulfamethoxazole / Trimethoprim Oral Suspension [Septra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","876427","Sulfamethoxazole 40 MG/ML / Trimethoprim 8 MG/ML [Septra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","876409","Gammar-P I.V. 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","876408","Immunoglobulin G Injectable Solution [Gammar]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","876407","Immunoglobulin G, Human 50 MG/ML [Gammar]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","864661","efavirenz 600 MG / lamiVUDine 300 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","864660","efavirenz / lamiVUDine / tenofovir disoproxil Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","864650","Zirgan 0.15 % Ophthalmic Gel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","864649","Ganciclovir Ophthalmic Gel [Zirgan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","864648","Ganciclovir 0.0015 MG/MG [Zirgan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","864647","Zirgan","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","863562","Valcyte 50 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","863561","valGANciclovir Oral Solution [Valcyte]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","863560","valGANciclovir 50 MG/ML [Valcyte]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","863559","valGANciclovir 50 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","863558","valGANciclovir Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","863557","valGANciclovir 50 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","861032","Viracept 0.05 MG/MG Oral Powder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","861031","Nelfinavir Oral Powder [Viracept]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","861030","Nelfinavir 0.05 MG/MG [Viracept]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859865","Invirase 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859864","saquinavir mesylate 500 MG [Invirase]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859863","saquinavir mesylate 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859862","saquinavir mesylate 500 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859861","Invirase 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859860","saquinavir mesylate 200 MG [Invirase]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859859","saquinavir mesylate 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859858","saquinavir mesylate 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","859857","saquinavir mesylate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","85762","Ritonavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856612","Rescriptor 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856611","Delavirdine Mesylate 200 MG [Rescriptor]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856610","Delavirdine Mesylate 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856609","Delavirdine Mesylate 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856562","Rescriptor 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856561","Delavirdine Mesylate 100 MG [Rescriptor]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856560","Delavirdine Mesylate 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","856559","Delavirdine Mesylate 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","850457","Prezista 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","850456","darunavir 150 MG [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","850455","darunavir 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","850454","darunavir 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","849580","Bactrim DS 800 MG / 160 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","849579","Sulfamethoxazole 800 MG / Trimethoprim 160 MG [Bactrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847749","Kaletra Solution 80/20 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847748","lopinavir / Ritonavir Oral Solution [Kaletra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847747","lopinavir 80 MG/ML / Ritonavir 20 MG/ML [Kaletra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847745","Kaletra 100 MG / 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847743","lopinavir 100 MG / Ritonavir 25 MG [Kaletra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847741","Kaletra 200 MG / 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847740","lopinavir / Ritonavir Oral Tablet [Kaletra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","847739","lopinavir 200 MG / Ritonavir 50 MG [Kaletra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","83816","Delavirdine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","83395","Saquinavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","833173","Sporanox PulsePak","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","833172","{28 (Itraconazole 100 MG Oral Capsule) } Pack","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","833164","Sporanox 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","833163","Itraconazole Oral Capsule [Sporanox]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","833162","Itraconazole 100 MG [Sporanox]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","831870","Prezista 75 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","831869","darunavir 75 MG [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","831868","darunavir 75 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","831867","darunavir 75 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","83171","Cidofovir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","83170","Vistide","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","825321","Zovirax 5 % Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824876","Prezista 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824875","darunavir 400 MG [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824338","darunavir 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824337","darunavir 400 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824002","Septra DS 800/160 Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824001","Sulfamethoxazole / Trimethoprim Oral Tablet [Septra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","824000","Sulfamethoxazole 800 MG / Trimethoprim 160 MG [Septra]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","805515","Aptivus 100 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","805514","tipranavir Oral Solution [Aptivus]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","805513","tipranavir 100 MG/ML [Aptivus]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","802321","tipranavir 100 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","802320","tipranavir Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","802319","tipranavir 100 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","797557","GamaSTAN 180 UNT/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","797556","Immunoglobulin G Injectable Solution [GamaSTAN]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","797555","Immunoglobulin G, Human 180 UNT/ML [GamaSTAN]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","797554","GamaSTAN","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","797553","Immunoglobulin G, Human 180 UNT/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","797551","Immunoglobulin G, Human 180 UNT/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","794610","Prezista 600 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","794609","darunavir 600 MG [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","76162","Rifater","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758999","Privigen 10 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758998","Immunoglobulin G Injectable Solution [Privigen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758997","Immunoglobulin G, Human 100 MG/ML [Privigen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758996","Privigen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758555","Intelence 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758554","etravirine Oral Tablet [Intelence]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758553","etravirine 100 MG [Intelence]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","758552","Intelence","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","757692","Nevirapine 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","756806","Zidovudine Oral Solution [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","756805","Zidovudine Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","756209","Zidovudine 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","755298","Retrovir 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","754761","etravirine 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","754760","etravirine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","754759","etravirine 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","746645","lopinavir 100 MG / Ritonavir 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","746644","Ritonavir 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","746643","lopinavir 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744846","ISENTRESS 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744845","raltegravir Oral Tablet [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744844","raltegravir 400 MG [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744843","ISENTRESS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744842","raltegravir 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744841","raltegravir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","744840","raltegravir 400 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","732","Amphotericin B","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","723827","Lexiva 50 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","723826","fosamprenavir Oral Suspension [Lexiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","723825","fosamprenavir 50 MG/ML [Lexiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","719872","raltegravir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","706237","Didanosine Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","706046","Didanosine Enteric Coated Capsule [Videx EC]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","706045","Didanosine Enteric Coated Capsule [Videx]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","706018","Delavirdine Oral Tablet [Rescriptor]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","70223","Aldesleukin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","701858","Aczone 5 % Topical Gel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","701857","Dapsone Topical Gel [Aczone]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","701856","Dapsone 0.05 MG/MG [Aczone]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","692960","Amphotericin B / Tetracycline","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","690741","sulfADIAZINE / Sulfamerazine / Sulfamethazine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","68244","lamiVUDine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","670026","darunavir 600 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","670025","darunavir 600 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","664743","Reyataz 300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","664742","Atazanavir 300 MG [Reyataz]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","664741","Atazanavir 300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","664740","Atazanavir 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","646830","DAUNOrubicin Liposomal 2 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","646829","DAUNOrubicin Liposomal Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","646828","DAUNOrubicin Liposomal 2 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643077","darunavir Oral Tablet [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643075","Prezista","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643074","darunavir 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643073","darunavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643072","darunavir 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643070","Atripla 600/200/300 Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643069","efavirenz / emtricitabine / tenofovir disoproxil Oral Tablet [Atripla]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643068","efavirenz 600 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG [Atripla]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643067","Atripla","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643066","efavirenz 600 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","643065","efavirenz / emtricitabine / tenofovir disoproxil Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","639888","Truvada (emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG (tenofovir disoproxil 245 MG) ) Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","639887","emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG [Truvada]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","632427","tenofovir disoproxil Oral Tablet [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","632025","tenofovir disoproxil Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","631357","INH 150 MG / Rifampin 300 MG Oral Capsule [IsonaRif]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","631356","isoniazid / Rifampin Oral Capsule [IsonaRif]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","631355","isoniazid 150 MG / Rifampin 300 MG [IsonaRif]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","631354","IsonaRif","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","617621","Vivaglobin 16 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","617620","Immunoglobulin G Injectable Solution [Vivaglobin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","617619","Immunoglobulin G, Human 160 MG/ML [Vivaglobin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","616633","Vivaglobin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","616148","Emtriva 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","616147","emtricitabine Oral Solution [Emtriva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","616146","emtricitabine 10 MG/ML [Emtriva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","614593","Aptivus","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","614534","abacavir / Lamivudine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","607295","Dapsone 0.05 MG/MG Topical Gel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","607294","Dapsone Topical Gel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","607293","Dapsone 0.05 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","607273","Vitrasert 4.5 MG Drug Implant","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","607272","Ganciclovir Drug Implant [Vitrasert]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","607271","Ganciclovir 4.5 MG [Vitrasert]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","606479","Gammagard 100 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","606478","Immunoglobulin G Injectable Solution [Gammagard]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","606477","Immunoglobulin G, Human 100 MG/ML [Gammagard]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","605173","Aczone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","604020","Ganciclovir 4.5 MG Drug Implant","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","604019","Ganciclovir Drug Implant","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","604018","Ganciclovir 4.5 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","603378","Aptivus 250 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","603377","tipranavir Oral Capsule [Aptivus]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","603376","tipranavir 250 MG [Aptivus]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","602395","abacavir 600 MG / Lamivudine 300 MG Oral Tablet [Epzicom]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","602394","abacavir 600 MG / Lamivudine 300 MG [Epzicom]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","602393","abacavir 600 MG / Lamivudine 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","602392","abacavir 600 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597730","lopinavir 200 MG / Ritonavir 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597729","lopinavir / Ritonavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597728","Ritonavir 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597727","lopinavir 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","59763","Stavudine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597291","emtricitabine 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597290","emtricitabine Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597289","emtricitabine 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597267","fosamprenavir 50 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597266","fosamprenavir Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","597265","fosamprenavir 50 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","591533","sulfADIAZINE / Trimethoprim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","577212","tipranavir 250 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","577211","tipranavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","577210","tipranavir 250 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","576513","emtricitabine 200 MG [Emtriva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","576416","enfuvirtide 90 MG/ML [Fuzeon]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","576110","fosamprenavir 700 MG [Lexiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","576103","Atazanavir 100 MG [Reyataz]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","576102","Atazanavir 150 MG [Reyataz]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","576101","Atazanavir 200 MG [Reyataz]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","575950","lamiVUDine 300 MG [Epivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","575878","efavirenz 600 MG [Sustiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","575802","Tenofovir disoproxil fumarate 300 MG [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","575271","Immunoglobulin G, Human 120 MG/ML [Carimune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","575077","abacavir 300 MG / Lamivudine 150 MG / Zidovudine 300 MG [Trizivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","575014","valGANciclovir 450 MG [Valcyte]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","574929","Didanosine 125 MG [Videx]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","574572","Trimethoprim 10 MG/ML [Primsol]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573579","Acyclovir 50 MG/ML [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573569","Acyclovir 800 MG [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573372","lamiVUDine 5 MG/ML [Epivir HBV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573371","lamiVUDine 100 MG [Epivir HBV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573349","abacavir 20 MG/ML [Ziagen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573348","abacavir 300 MG [Ziagen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573298","Nevirapine 10 MG/ML [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573286","efavirenz 50 MG [Sustiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573284","efavirenz 200 MG [Sustiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","573017","lamiVUDine 150 MG / Zidovudine 300 MG [Combivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","572422","Nelfinavir 250 MG [Viracept]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","571769","Nevirapine 200 MG [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","571699","Cidofovir 75 MG/ML [Vistide]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","570534","Acyclovir 0.05 MG/MG [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","569301","Trimethoprim 100 MG [Trimpex]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","569148","Polymyxin B 10000 UNT/ML / Trimethoprim 1 MG/ML [Polytrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","569113","Sulfamethoxazole 400 MG / Trimethoprim 80 MG [Bactrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","569104","Sulfamethoxazole 40 MG/ML / Trimethoprim 8 MG/ML [Sulfatrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","568199","Rifampin 60 MG/ML [Rifadin IV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","567918","Flucytosine 500 MG [Ancobon]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","567916","Flucytosine 250 MG [Ancobon]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","567900","Fluconazole 100 MG [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","567515","isoniazid 150 MG / Rifampin 300 MG [Rifamate]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","567511","isoniazid 50 MG / Pyrazinamide 300 MG / Rifampin 120 MG [Rifater]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566742","Immunoglobulin G, Human 100 MG/ML [Polygam S/D]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566738","Immunoglobulin G, Human 50 MG/ML [Iveegam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566736","Immunoglobulin G, Human 100 MG/ML [Venoglobulin-S 10%]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566631","Ganciclovir 50 MG/ML [Cytovene]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","5666","Immunoglobulin G","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566054","Pyrimethamine 25 MG [Daraprim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566052","Zidovudine 100 MG [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566051","Acyclovir 400 MG [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566049","Acyclovir 40 MG/ML [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566048","Acyclovir 200 MG [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566047","Fluconazole 40 MG/ML [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566046","Fluconazole 10 MG/ML [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566045","Fluconazole 2 MG/ML [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566044","Fluconazole 200 MG [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","566037","Rifampin 150 MG [Rifadin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565345","Stavudine 1 MG/ML [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565300","Immunoglobulin G, Human 50 MG/ML [Octagam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565179","Indinavir 400 MG [Crixivan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565178","Indinavir 200 MG [Crixivan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565135","Ritonavir 80 MG/ML [Norvir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565134","Ritonavir 100 MG [Norvir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565120","Stavudine 40 MG [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565119","Stavudine 30 MG [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565118","Stavudine 20 MG [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565117","Stavudine 15 MG [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565112","lamiVUDine 10 MG/ML [Epivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565111","lamiVUDine 150 MG [Epivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","565059","Zidovudine 300 MG [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","564526","Zidovudine 10 MG/ML [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","564144","Aldesleukin 1.1 MG/ML [Proleukin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","564028","Fluconazole 150 MG [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","564027","Fluconazole 50 MG [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","564013","Rifampin 300 MG [Rimactane]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","563142","Rifampin 300 MG [Rifadin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","562707","Trimethoprim 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","547199","Baygam 150 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","547198","Immunoglobulin G Injectable Solution [Baygam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","547197","Immunoglobulin G, Human 150 MG/ML [Baygam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","547196","Immunoglobulin G, Human 150 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","547195","Immunoglobulin G, Human 150 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545188","Sporanox 10 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545187","Itraconazole Injectable Solution [Sporanox]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545186","Itraconazole 10 MG/ML [Sporanox]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545184","Gamunex-C 10 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545183","Immunoglobulin G Injectable Solution [Gamunex]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545182","Immunoglobulin G, Human 100 MG/ML [Gamunex]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545179","Gammagard S/D 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","545178","Immunoglobulin G, Human 50 MG/ML [Gammagard S/D]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","542370","Viracept 625 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","542369","Nelfinavir 625 MG [Viracept]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","542059","Videx 20 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","542058","Didanosine 20 MG/ML [Videx]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","541558","Flebogamma 5 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","541557","Immunoglobulin G Injectable Solution [Flebogamma]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","541556","Immunoglobulin G, Human 50 MG/ML [Flebogamma]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","541555","Flebogamma","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","541058","Crixivan 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","541057","Indinavir 100 MG [Crixivan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","540398","emtricitabine / tenofovir disoproxil Oral Tablet [Truvada]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","540395","emtricitabine / tenofovir disoproxil Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","539824","abacavir / Lamivudine Oral Tablet [Epzicom]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","539804","Saquinavir Oral Tablet [Invirase]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","539698","Didanosine 400 MG [Videx EC]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","539691","Didanosine 250 MG [Videx EC]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","539688","Didanosine 200 MG [Videx EC]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","53654","Nevirapine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","497184","Epzicom","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","495430","Truvada","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","485467","Saquinavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","476556","emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","476143","abacavir / Lamivudine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","475969","etravirine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","471329","Gamunex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","4678","Ganciclovir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","460132","darunavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","451785","sulfADIAZINE 410 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","451782","sulfADIAZINE / Trimethoprim Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","4451","Flucytosine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","4450","Fluconazole","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","440925","Itraconazole Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","437347","Acyclovir 2 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","42750","Iveegam","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","42697","Gammagard","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","419921","Didanosine 20 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","415660","Acyclovir 2 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406217","Stavudine 75 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406216","Stavudine 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406215","Stavudine 37.5 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406214","Stavudine Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406213","Stavudine 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406115","Nelfinavir 625 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406055","enfuvirtide Injectable Solution [Fuzeon]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406018","emtricitabine Oral Capsule [Emtriva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406017","emtricitabine Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","406016","emtricitabine 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","404587","Emtriva 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","404460","Fuzeon 90 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403978","Nelfinavir 625 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403875","emtricitabine 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403817","Stavudine 100 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403816","Stavudine 75 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403815","Stavudine 50 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403814","Stavudine 37.5 MG Extended Release Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403145","Fluconazole Oral Suspension [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","403126","Acyclovir Topical Cream [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402626","Trimethoprim 20 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402415","enfuvirtide Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402414","enfuvirtide 90 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402370","Atazanavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402367","fosamprenavir Oral Tablet [Lexiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402366","fosamprenavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402364","fosamprenavir 700 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402335","Atazanavir 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402334","Atazanavir 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402333","Atazanavir Oral Capsule [Reyataz]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402332","Atazanavir 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402247","Atazanavir 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402246","Atazanavir 150 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402245","Atazanavir 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402110","Lexiva 700 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402109","fosamprenavir 700 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402108","Lexiva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402095","Reyataz 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402094","Reyataz 150 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","402093","Reyataz 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","401981","enfuvirtide 90 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","393562","Stavudine Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","393334","Tenofovir disoproxil fumarate 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","393324","Ganciclovir Ophthalmic Gel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","393323","Ganciclovir 0.0015 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","392458","Dapsone / Pyrimethamine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","388052","Ganciclovir 0.0015 MG/MG Ophthalmic Gel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","386065","Immunoglobulin G Injectable Solution [Octagam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","385979","Itraconazole Oral Solution [Sporanox]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","385496","Immunoglobulin G, Human 160 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","384480","Didanosine 1.67 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","384478","Didanosine 2.5 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","384477","Didanosine 1 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","383858","Emtriva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","382467","Reyataz","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","379128","Polymyxin B / Trimethoprim Ophthalmic Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","379127","Zalcitabine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","379126","Zidovudine Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","378973","Amphotericin B Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","378707","Indinavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","378651","Itraconazole Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","378299","efavirenz Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","378235","Nelfinavir Oral Powder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377580","Amphotericin B Topical Lotion","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377568","Acyclovir Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377223","Itraconazole Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377143","Acyclovir Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377136","Cidofovir Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377117","Sulfamethoxazole / Trimethoprim Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377114","Rifampin Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377091","Aldesleukin Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","377071","Fluconazole Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","376663","Ganciclovir Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","376660","Amphotericin B Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","376640","sulfADIAZINE / Sulfamerazine / Sulfamethazine Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","376438","Amphotericin B Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","375982","Trimethoprim Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","375802","Didanosine Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","375072","Flucytosine Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374813","abacavir / Lamivudine / Zidovudine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374656","valGANciclovir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374643","lopinavir / Ritonavir Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374642","lopinavir / Ritonavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374595","Nevirapine Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374473","Acyclovir Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374332","Zidovudine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374331","Zidovudine Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374234","Sulfamethoxazole / Trimethoprim Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374233","Sulfamethoxazole / Trimethoprim Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374230","Trimethoprim Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374229","Trimethoprim Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","374059","Amphotericin B / Tetracycline Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373979","Pyrimethamine / Sulfadoxine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373977","sulfADIAZINE Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373959","Stavudine Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373825","Saquinavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373796","Ritonavir Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373795","Ritonavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373783","Rifampin Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373781","Rifampin Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373718","Pyrimethamine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373046","Nevirapine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","373015","Nelfinavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372564","lamiVUDine / Zidovudine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372563","lamiVUDine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372562","lamiVUDine Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372509","isoniazid / Rifampin Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372508","isoniazid / Rifampin Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372292","Ganciclovir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372212","Flucytosine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372211","Flucytosine Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372210","Fluconazole Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372209","Fluconazole Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372208","Fluconazole Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","372003","efavirenz Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","371819","Didanosine Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","371699","Delavirdine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","371690","Dapsone / Pyrimethamine Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","371689","Dapsone Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370912","Amprenavir Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370911","Amprenavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370782","Acyclovir Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370725","Itraconazole Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370684","Indinavir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370583","Amphotericin B Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370537","Acyclovir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370536","Acyclovir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370503","abacavir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","370502","abacavir Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","369334","Pyrimethamine Oral Tablet [Daraprim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","369244","Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","369227","Trimethoprim Oral Tablet [Trimpex]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368877","isoniazid / Pyrazinamide / Rifampin Oral Tablet [Rifater]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368780","Fluconazole Oral Tablet [Diflucan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368582","efavirenz Oral Tablet [Sustiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368418","Nelfinavir Oral Tablet [Viracept]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368309","lamiVUDine / Zidovudine Oral Tablet [Combivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368253","abacavir Oral Tablet [Ziagen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368247","lamiVUDine Oral Tablet [Epivir HBV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368174","Acyclovir Oral Tablet [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368153","abacavir / Lamivudine / Zidovudine Oral Tablet [Trizivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","368141","valGANciclovir Oral Tablet [Valcyte]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","367794","lamiVUDine Oral Tablet [Epivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","367746","Nevirapine Oral Tablet [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","367700","Zidovudine Oral Tablet [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","367387","Acyclovir Topical Ointment [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366740","isoniazid / Rifampin Oral Capsule [Rifamate]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366732","Rifampin Oral Capsule [Rifadin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366731","Rifampin Oral Capsule [Rimactane]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366708","Stavudine Oral Capsule [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366687","Zidovudine Oral Capsule [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366550","Acyclovir Oral Capsule [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366448","efavirenz Oral Capsule [Sustiva]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366441","Indinavir Oral Capsule [Crixivan]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366398","Ritonavir Oral Capsule [Norvir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366292","Saquinavir Oral Capsule [Invirase]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366217","Flucytosine Oral Capsule [Ancobon]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366081","Nevirapine Oral Suspension [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","366069","Acyclovir Oral Suspension [Zovirax]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364697","lamiVUDine Oral Solution [Epivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364692","Ritonavir Oral Solution [Norvir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364596","abacavir Oral Solution [Ziagen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364593","lamiVUDine Oral Solution [Epivir HBV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364584","Didanosine Oral Solution [Videx]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364572","Trimethoprim Oral Solution [Primsol]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","364319","Stavudine Oral Solution [Zerit]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","363461","Immunoglobulin G Injectable Solution [Venoglobulin-S 10%]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","363453","Rifampin Injectable Solution [Rifadin IV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362931","Cidofovir Injectable Solution [Vistide]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362878","Zidovudine Injectable Solution [Retrovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362823","Ganciclovir Injectable Solution [Cytovene]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362781","Immunoglobulin G Injectable Solution [Carimune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362693","Immunoglobulin G Injectable Solution [Polygam S/D]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362673","Aldesleukin Injectable Solution [Proleukin]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362579","Immunoglobulin G Injectable Solution [Gammagard S/D]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","362567","Immunoglobulin G Injectable Solution [Iveegam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","358418","Amphotericin B 30 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","358262","fosamprenavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","356743","Fuzeon","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","353492","Immunoglobulin G, Human 0.2 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","352504","Carimune","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","352230","Epivir 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","352143","Sustiva 600 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","352050","Viread 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","351326","Carimune 12 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","351129","Immunoglobulin G, Human 0.2 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","351086","Indinavir 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","350655","lamiVUDine 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","350652","efavirenz 600 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","349491","lamiVUDine 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","349477","efavirenz 600 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","349251","Tenofovir disoproxil fumarate 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","348506","Itraconazole 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","346473","Immunoglobulin G, Human 50 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","343818","Immunoglobulin G, Human 100 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","343815","Immunoglobulin G, Human 120 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","343725","Acyclovir 50 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","343047","Atazanavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","34246","Polymyxin B / Trimethoprim Ophthalmic Solution [Polytrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","340674","sulfADIAZINE 33.4 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","340137","Nelfinavir 0.05 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","340089","Acyclovir 0.05 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","337558","Trimethoprim 90 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","336956","Indinavir 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","3364","Didanosine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","3363","Zalcitabine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","335921","Rifampin 120 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","333409","Trimethoprim 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","333250","Rifampin 450 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","332959","Pyrimethamine 12.5 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","332450","Ritonavir 20 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","332349","Aldesleukin 1.1 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","331952","Flucytosine 0.01 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","331565","valGANciclovir 450 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","331538","lopinavir 80 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","331537","Ritonavir 33.3 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","331536","lopinavir 133 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","331497","Trimethoprim 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330837","Nelfinavir 250 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330816","Didanosine 250 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330786","Didanosine 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330498","Stavudine 40 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330440","Ganciclovir 250 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330321","Didanosine 400 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330320","Didanosine 20 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330319","Didanosine 125 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","330243","Stavudine 1 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329867","Indinavir 400 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329866","Indinavir 333 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329485","abacavir 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329484","abacavir 20 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329267","Amprenavir 15 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329266","Amprenavir 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329265","Amprenavir 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","329180","Indinavir 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328839","Zalcitabine 0.75 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328838","Zalcitabine 0.375 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328720","Trimethoprim 1 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328627","Stavudine 30 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328625","Stavudine 20 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328624","Stavudine 15 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328503","Rifampin 60 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328300","Amphotericin B 0.03 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","328280","Ganciclovir 50 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","323964","Rifampin 600 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","323726","Viread","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","322248","Tenofovir disoproxil fumarate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","318218","sulfADIAZINE 33.4 MG/ML / Sulfamerazine 33.4 MG/ML / Sulfamethazine 33.4 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317612","Acyclovir 40 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317538","Zidovudine 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317528","Trimethoprim 80 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317527","Trimethoprim 16 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317489","Saquinavir 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317488","Ritonavir 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317397","lamiVUDine 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317394","Itraconazole 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317374","Fluconazole 40 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317373","Fluconazole 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317359","efavirenz 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","317150","Ritonavir 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316992","Lozenge","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316916","Zidovudine 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316915","Zidovudine 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316867","Trimethoprim 8 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316865","Trimethoprim 160 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316864","Trimethoprim 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316739","sulfADIAZINE 500 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316647","Ritonavir 80 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316642","Rifampin 300 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316641","Rifampin 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316613","Pyrimethamine 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316334","Nevirapine 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316333","Nevirapine 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316128","lamiVUDine 5 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316127","lamiVUDine 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316126","lamiVUDine 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","316113","Itraconazole 10 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315974","Ganciclovir 500 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315941","Flucytosine 500 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315940","Flucytosine 250 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315939","Fluconazole 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315938","Fluconazole 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315937","Fluconazole 2 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315936","Fluconazole 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315935","Fluconazole 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315853","efavirenz 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315852","efavirenz 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315807","Didanosine 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315806","Didanosine 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315805","Didanosine 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315804","Didanosine 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315760","Dapsone 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315759","Dapsone 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315674","Cidofovir 75 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315374","Amphotericin B 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315373","Amphotericin B 5 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315372","Amphotericin B 100 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315282","Acyclovir 800 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315281","Acyclovir 400 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315280","Acyclovir 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","315217","Stavudine 1 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","314007","Ganciclovir 250 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313961","Didanosine 200 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313812","Acyclovir 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313760","Zalcitabine 0.75 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313759","Zalcitabine 0.375 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313566","valGANciclovir 450 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313137","Sulfamethoxazole 80 MG/ML / Trimethoprim 16 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313134","Sulfamethoxazole 40 MG/ML / Trimethoprim 8 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313110","Stavudine 40 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313109","Stavudine 30 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313108","Stavudine 20 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","313107","Stavudine 15 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","312821","Rifampin 60 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311943","Nevirapine 10 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311925","Nelfinavir 0.05 MG/MG Oral Powder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311924","Nelfinavir 250 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311369","lopinavir 80 MG/ML / Ritonavir 20 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311368","lopinavir 133 MG / Ritonavir 33.3 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311205","Itraconazole 10 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","311204","Itraconazole 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310988","Indinavir 400 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310987","Indinavir 333 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310986","Indinavir 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","3108","Dapsone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310495","Immunoglobulin G, Human 120 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310494","Immunoglobulin G, Human 100 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310442","Ganciclovir 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310353","Fluconazole 40 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","310352","Fluconazole 10 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309873","Didanosine 50 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309872","Didanosine 25 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309871","Didanosine 2.5 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309869","Didanosine 1.67 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309868","Didanosine 150 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309867","Didanosine 1 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","309866","Didanosine 100 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","308206","Amphotericin B 50 MG / Tetracycline 250 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","307816","Aldesleukin 1.1 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","307730","Acyclovir 40 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","307650","abacavir 300 MG / Lamivudine 150 MG / Zidovudine 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","304959","Valcyte","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","300195","tenofovir disoproxil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","285028","abacavir 300 MG / Lamivudine 150 MG / Zidovudine 300 MG Oral Tablet [Trizivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","285027","Videx EC 250 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284988","Didanosine 400 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284914","Videx EC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284904","Trizivir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284756","Kaletra","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284640","lopinavir / Ritonavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284620","abacavir / Lamivudine / Zidovudine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284587","Valcyte 450 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284500","Videx EC 400 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284499","Videx EC 200 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284498","Videx 125 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284185","Didanosine 200 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284184","Didanosine 250 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","284183","Didanosine 125 MG Enteric Coated Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","283103","Indinavir 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","281","Acyclovir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","28031","Itraconazole","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","276237","emtricitabine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","275891","valGANciclovir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","261620","Primsol","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","261457","Baygam","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","261353","Primsol 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","252619","Amprenavir 15 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","252618","Amprenavir 150 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","252617","Amprenavir 50 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","252432","Fluconazole 2 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","245837","sulfADIAZINE 410 MG / Trimethoprim 90 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","244967","Polymyxin B 10000 UNT/ML / Trimethoprim 1 MG/ML Ophthalmic Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","244413","Amphotericin B 0.03 MG/MG Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","242692","lamiVUDine 5 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","242680","abacavir 20 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","242679","abacavir 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","240572","isoniazid / Pyrazinamide / Rifampin Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","239240","Amphotericin B 5 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","228656","Amprenavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","227633","Ancobon","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","226026","Octagam","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","224922","Trimpex","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","224890","Viramune","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","221052","abacavir sulfate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","221017","Ziagen","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","220910","Vitrasert","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","220772","Venoglobulin-S 10%","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","220093","Sulfamethoxazole / Trimethoprim Oral Suspension [Sulfatrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","220091","Sulfatrim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","219679","Rifamate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","219678","Rifadin IV","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","219314","Polymyxin B / Trimethoprim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","219312","Polygam S/D","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","217247","Gammagard S/D","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","216937","Epivir HBV","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","214671","lamiVUDine / Zidovudine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","214662","isoniazid / Pyrazinamide / Rifampin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","214468","DAUNOrubicin Liposomal","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213706","Zovirax 800 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213694","Zovirax 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213484","Epivir HBV 5 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213483","Epivir HBV 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213461","abacavir 20 MG/ML Oral Solution [Ziagen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213460","abacavir 300 MG Oral Tablet [Ziagen]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213405","Viramune 10 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213392","Sustiva 50 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213390","Sustiva 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","213088","3TC 150 MG / AZT 300 MG Oral Tablet [Combivir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","212118","Viracept 250 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","211327","Viramune 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","211248","Vistide 75 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","209977","Zovirax 5 % Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","208631","Trimpex 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","208451","Polymyxin B 10000 UNT/ML / TMP 1 MG/ML Ophthalmic Solution [Polytrim]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","208416","Bactrim 400 MG / 80 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","208406","Sulfatrim 200/40 MG per 5 ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207436","Rifadin IV 60 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207127","Ancobon 500 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207125","Ancobon 250 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207112","Diflucan 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207108","Diflucan 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207107","Diflucan 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","207106","Diflucan 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","206702","Rifamate 150 MG-300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","206698","INH 50 MG / PZA 300 MG / Rifampin 120 MG Oral Tablet [Rifater]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205853","Polygam S/D 10 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205849","Iveegam 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205847","Venoglobulin-S 10 % 100 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205743","Cytovene 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205328","lamiVUDine 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205292","efavirenz 50 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205291","efavirenz 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","205290","efavirenz 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","204569","Immunoglobulin G Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","204534","Zidovudine 10 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","204406","Immunoglobulin G, Human 50 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","203760","Proleukin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","203748","Zerit","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","203743","Cytovene","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","203674","Invirase","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","203608","Crixivan","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","203218","Pyrimethamine / Sulfadoxine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202954","Rimactane","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202953","Rifadin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202943","Rescriptor","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202826","Sporanox","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202813","Diflucan","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202807","Septra","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","202791","Retrovir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201912","Daraprim 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201907","Retrovir 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201905","Zovirax 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201903","Zovirax 40 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201901","Diflucan 40 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201900","Diflucan 10 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201899","Diflucan 2 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201868","Rifadin 300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","201867","Rifadin 150 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","200206","Ganciclovir 500 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","200105","Saquinavir 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","200082","lamiVUDine 150 MG / Zidovudine 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199950","Fluconazole 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199802","Rifampin 450 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199756","isoniazid 150 MG / Rifampin 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199755","isoniazid 100 MG / Rifampin 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199748","Flucytosine 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199747","Fluconazole 50 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199746","Fluconazole 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199745","Fluconazole 150 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199663","Zidovudine 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199620","Rifampin 600 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199524","Acyclovir 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199470","Flucytosine 0.01 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199422","Nevirapine 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199388","Cidofovir 75 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199332","Trimethoprim 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199264","Amphotericin B 100 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199249","Ritonavir 80 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199148","lamiVUDine 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","199147","lamiVUDine 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198384","isoniazid 50 MG / Pyrazinamide 300 MG / Rifampin 120 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198352","Zidovudine 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198335","Sulfamethoxazole 800 MG / Trimethoprim 160 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198334","Sulfamethoxazole 400 MG / Trimethoprim 80 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198332","Trimethoprim 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198229","Pyrimethamine 25 MG / Sulfadoxine 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198228","sulfADIAZINE 500 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198203","isoniazid 150 MG / Rifampin 300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198202","Rifampin 300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198201","Rifampin 150 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","198182","Pyrimethamine 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197703","Flucytosine 500 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197702","Flucytosine 250 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197701","Fluconazole 50 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197700","Fluconazole 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197699","Fluconazole 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197698","Fluconazole 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197558","Dapsone 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197557","Dapsone 100 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197368","Amphotericin B 30 MG/ML Topical Lotion","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197367","Amphotericin B 30 MG/ML Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197313","Acyclovir 800 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197312","Acyclovir 0.05 MG/MG Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197311","Acyclovir 400 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","197310","Acyclovir 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","196479","Norvir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","196478","Epivir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","195088","lopinavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","195085","efavirenz","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","195084","Sustiva","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","192254","Combivir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","190548","tipranavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","190521","abacavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","153652","Zerit 1 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","153530","Octagam 5 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","153128","Crixivan 400 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","153127","Crixivan 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152971","Norvir 80 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152970","Norvir 100 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152944","Zerit 40 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152943","Zerit 30 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152942","Zerit 20 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152941","Zerit 15 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152932","Epivir 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152931","Epivir 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152854","Sporanox 10 MG/ML Oral Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152772","Retrovir 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152606","DaunoXome","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152535","Zovirax","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","152494","Videx","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","151583","Daraprim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","151399","Bactrim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486841","ISENTRESS 20 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486840","ISENTRESS Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486839","raltegravir Oral Suspension [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486838","raltegravir 20 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486821","raltegravir 20 MG/ML [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486819","raltegravir 20 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486579","raltegravir Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1486578","raltegravir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1426680","Immunoglobulin G, Human","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1423662","Acyclovir 50 MG Buccal Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1423661","Acyclovir Buccal Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1423660","Acyclovir Buccal Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1423659","Acyclovir 50 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","142152","Delavirdine Mesylate","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1421195","raltegravir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1421185","raltegravir Chewable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","142118","Sulfamethoxazole 100 MG / Trimethoprim 20 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1421179","raltegravir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","142061","Immunoglobulin G, Human 160 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","141859","Acyclovir 50 MG/ML Topical Cream","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","139896","enfuvirtide","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1373747","24 HR Viramune 100 MG Extended Release Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1373746","Nevirapine 100 MG [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1373745","24 HR Nevirapine 100 MG Extended Release Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1364428","Bivigam 10 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1364427","Bivigam Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1364426","Immunoglobulin G Injectable Solution [Bivigam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1364425","Immunoglobulin G, Human 100 MG/ML [Bivigam]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1364424","Bivigam","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1359271","Prezista 800 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1359270","darunavir 800 MG [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1359269","darunavir 800 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1359268","darunavir 800 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","134527","Nelfinavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","134526","Viracept","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306298","Stribild (cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300) Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306297","Stribild Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306296","Stribild Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306295","cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet [Stribild]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306294","cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG [Stribild]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306293","Stribild","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306292","cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306291","cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306290","cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306289","cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306288","cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306287","elvitegravir 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306286","elvitegravir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306285","cobicistat 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1306284","cobicistat","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1297007","ISENTRESS Chewable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1296770","Viracept Oral Powder Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1295865","Viread Oral Powder Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1295588","Didanosine Chewable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1295148","tenofovir disoproxil Oral Powder Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1295040","Nelfinavir Oral Powder Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1294702","Lozenge Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1294701","Buccal Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","128790","Polytrim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250723","Intelence 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250722","etravirine 25 MG [Intelence]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250721","etravirine 25 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250720","etravirine 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250672","Lidovir (acyclovir 4 % / lidocaine hydrochloride 4 % ) Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250671","Lidovir Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250670","Acyclovir / Lidocaine Topical Ointment [Lidovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250669","Acyclovir 0.04 MG/MG / Lidocaine Hydrochloride 0.04 MG/MG [Lidovir]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250668","Lidovir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250667","Acyclovir 0.04 MG/MG / Lidocaine Hydrochloride 0.04 MG/MG Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250666","Acyclovir / Lidocaine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250665","Acyclovir / Lidocaine Topical Ointment","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250664","Acyclovir / Lidocaine Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1250663","Acyclovir 0.04 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243346","Viread 0.04 MG/MG Oral Powder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243345","tenofovir disoproxil Oral Powder [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243344","Tenofovir disoproxil fumarate 0.04 MG/MG [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243343","Tenofovir disoproxil fumarate 0.04 MG/MG Oral Powder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243342","tenofovir disoproxil Oral Powder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243341","Tenofovir disoproxil fumarate 0.04 MG/MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243330","Viread 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243329","Tenofovir disoproxil fumarate 200 MG [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243328","Tenofovir disoproxil fumarate 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243327","Tenofovir disoproxil fumarate 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243326","Viread 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243325","Tenofovir disoproxil fumarate 150 MG [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243324","Tenofovir disoproxil fumarate 150 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243323","Tenofovir disoproxil fumarate 150 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243229","Viread 250 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243228","Tenofovir disoproxil fumarate 250 MG [Viread]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243227","Tenofovir disoproxil fumarate 250 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1243226","Tenofovir disoproxil fumarate 250 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236632","Prezista 100 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236631","Prezista Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236630","darunavir Oral Suspension [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236629","darunavir 100 MG/ML [Prezista]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236628","darunavir 100 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236627","darunavir Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236626","darunavir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1236625","darunavir 100 MG/ML","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235595","ISENTRESS 25 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235594","raltegravir 25 MG [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235593","raltegravir 25 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235592","raltegravir 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235591","ISENTRESS 100 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235590","raltegravir Chewable Tablet [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235589","raltegravir 100 MG [ISENTRESS]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235588","raltegravir 100 MG Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235587","raltegravir Chewable Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1235586","raltegravir 100 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232617","DaunoXome 2 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232616","DAUNOrubicin Liposomal Injectable Solution [DaunoXome]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232615","DAUNOrubicin Liposomal 2 MG/ML [DaunoXome]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232418","Onmel 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232417","Onmel Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232416","Onmel Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232415","Itraconazole Oral Tablet [Onmel]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232414","Itraconazole 200 MG [Onmel]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1232413","Onmel","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187773","Venoglobulin-S 10% Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187668","Zirgan Ophthalmic Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187397","Vivaglobin Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187271","Zerit Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187270","Zerit Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187269","Zerit Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187176","Vitrasert Drug Implant Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187173","Vistide Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187140","Valcyte Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187139","Valcyte Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1187138","Valcyte Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186974","Viread Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186973","Viread Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186809","Viramune Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186808","Viramune Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186807","Viramune Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186804","Viracept Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186803","Viracept Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186590","Videx Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186589","Videx Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186588","Videx Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186587","Videx EC Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186586","Videx EC Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186580","Victrelis Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186579","Victrelis Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186466","Zovirax Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186465","Zovirax Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186464","Zovirax Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186463","Zovirax Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186419","Xerese Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186158","Lexiva Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186157","Lexiva Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1186156","Lexiva Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1185615","Truvada Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1185614","Truvada Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1185594","Trizivir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1185593","Trizivir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1185473","Sustiva Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1185472","Sustiva Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184733","Rimactane Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184732","Rimactane Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184719","Rifater Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184718","Rifater Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184717","Rifamate Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184716","Rifamate Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184715","Rifadin Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184714","Rifadin Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184711","Rifadin IV Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184364","Trimpex Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184363","Trimpex Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1184053","Polytrim Ophthalmic Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1183776","Sulfatrim Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1183775","Sulfatrim Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1183529","Polygam S/D Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1183051","Reyataz Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1183050","Reyataz Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1182542","Retrovir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1182541","Retrovir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1182540","Retrovir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1182538","Retrovir Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1181886","Rescriptor Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1181885","Rescriptor Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1180698","Proleukin Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1180526","Octagam Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1180165","Septra Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1180164","Septra Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1180159","Septra Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1178922","Privigen Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1178271","Primsol Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1178270","Primsol Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177776","Sporanox Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177775","Sporanox Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177774","Sporanox Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177773","Sporanox Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177659","Prezista Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177658","Prezista Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177580","Norvir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177579","Norvir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1177578","Norvir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175949","Emtriva Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175948","Emtriva Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175947","Emtriva Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175770","Carimune Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175568","Ancobon Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175567","Ancobon Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175395","Gamunex Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175390","Gammar Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175389","Gammaplex Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175388","Gammaked Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175387","Gammagard S/D Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175386","Gammagard Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1175381","GamaSTAN Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1174702","Fuzeon Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1174489","Cytovene Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1173456","Invirase Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1173455","Invirase Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1173437","Intelence Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1173436","Intelence Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1173062","Crixivan Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1173061","Crixivan Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1172892","Atripla Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1172891","Atripla Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1172011","Incivek Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1172010","Incivek Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1171272","Hizentra Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1169951","Aczone Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1169034","Flebogamma Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168816","DaunoXome Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168647","Baygam Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168601","Aptivus Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168600","Aptivus Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168599","Aptivus Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168552","Kaletra Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168549","Kaletra Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168546","Kaletra Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168234","Epzicom Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168178","Diflucan Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168177","Diflucan Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168176","Diflucan Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168168","Daraprim Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1168167","Daraprim Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167959","Bactrim Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167956","Bactrim Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167643","Epzicom Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167631","Epivir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167630","Epivir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167629","Epivir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167628","Epivir HBV Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167627","Epivir HBV Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167626","Epivir HBV Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167548","Diflucan Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167417","Complera Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167416","Complera Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1167184","Iveegam Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1166891","Combivir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1166890","Combivir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1166639","IsonaRif Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1166638","IsonaRif Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1166567","ISENTRESS Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1166566","ISENTRESS Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165666","fosamprenavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165665","fosamprenavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165662","fosamprenavir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165487","Ritonavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165486","Ritonavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165485","Ritonavir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165466","Rifampin Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165465","Rifampin Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1165463","Rifampin Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1164168","Pyrimethamine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1164167","Pyrimethamine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1164166","Pyrimethamine / Sulfadoxine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1164165","Pyrimethamine / Sulfadoxine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163994","valGANciclovir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163993","valGANciclovir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163992","valGANciclovir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163920","Ganciclovir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163919","Ganciclovir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163918","Ganciclovir Ophthalmic Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163917","Ganciclovir Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163916","Ganciclovir Drug Implant Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163859","lopinavir / Ritonavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163858","lopinavir / Ritonavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163857","lopinavir / Ritonavir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163784","etravirine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163783","etravirine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163061","abacavir / lamiVUDine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163060","abacavir / lamiVUDine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163059","abacavir / lamiVUDine / Zidovudine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163058","abacavir / lamiVUDine / Zidovudine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163029","Zidovudine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163028","Zidovudine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163027","Zidovudine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163026","Zidovudine Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163024","Zalcitabine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1163023","Zalcitabine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162984","Sulfamethoxazole / Trimethoprim Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162983","Sulfamethoxazole / Trimethoprim Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162982","Sulfamethoxazole / Trimethoprim Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162981","Sulfamethoxazole / Trimethoprim Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162820","lamiVUDine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162819","lamiVUDine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162818","lamiVUDine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162817","lamiVUDine / Zidovudine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162816","lamiVUDine / Zidovudine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162350","sulfADIAZINE Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162349","sulfADIAZINE Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162344","sulfADIAZINE / Trimethoprim Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162343","sulfADIAZINE / Trimethoprim Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162340","sulfADIAZINE / Sulfamerazine / Sulfamethazine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162339","sulfADIAZINE / Sulfamerazine / Sulfamethazine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162111","tipranavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162110","tipranavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1162109","tipranavir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161890","enfuvirtide Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161889","emtricitabine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161888","emtricitabine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161887","emtricitabine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161886","emtricitabine / tenofovir disoproxil Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161885","emtricitabine / tenofovir disoproxil Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161745","Stavudine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161744","Stavudine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161743","Stavudine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161490","tenofovir disoproxil Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161489","tenofovir disoproxil Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161349","isoniazid / Rifampin Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161348","isoniazid / Rifampin Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161347","isoniazid / Pyrazinamide / Rifampin Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161346","isoniazid / Pyrazinamide / Rifampin Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161304","emtricitabine / Rilpivirine / tenofovir disoproxil Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161303","emtricitabine / Rilpivirine / tenofovir disoproxil Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161290","efavirenz Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161289","efavirenz Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161287","efavirenz / emtricitabine / tenofovir disoproxil Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161286","efavirenz / emtricitabine / tenofovir disoproxil Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161285","efavirenz / lamiVUDine / tenofovir disoproxil Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1161284","efavirenz / lamiVUDine / tenofovir disoproxil Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160885","telaprevir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160884","telaprevir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160240","Flucytosine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160239","Flucytosine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160238","Flucytosine Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160237","Fluconazole Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160236","Fluconazole Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160235","Fluconazole Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1160234","Fluconazole Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1159901","Polymyxin B / Trimethoprim Ophthalmic Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1159778","Itraconazole Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1159777","Itraconazole Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1159776","Itraconazole Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1159775","Itraconazole Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1158827","Trimethoprim Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1158826","Trimethoprim Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1158825","Trimethoprim Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1158094","Nevirapine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1158093","Nevirapine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1158092","Nevirapine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1157612","Saquinavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1157611","Saquinavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1157537","Nelfinavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1157536","Nelfinavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1157185","darunavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1157184","darunavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1156307","Indinavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1156306","Indinavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1156296","Immunoglobulin G Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1155330","boceprevir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1155329","boceprevir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1154611","Aldesleukin Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1154365","Atazanavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1154364","Atazanavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153463","Acyclovir Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153462","Acyclovir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153461","Acyclovir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153460","Acyclovir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153458","Acyclovir Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153457","Acyclovir / Hydrocortisone Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153204","Amprenavir Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153203","Amprenavir Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1153202","Amprenavir Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152917","Amphotericin B Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152915","Amphotericin B Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152914","Amphotericin B Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152913","Amphotericin B Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152910","Amphotericin B / Tetracycline Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152909","Amphotericin B / Tetracycline Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152174","Delavirdine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152173","Delavirdine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152145","DAUNOrubicin Liposomal Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1152142","Dapsone Topical Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151859","Dapsone Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151858","Dapsone Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151855","Dapsone / Pyrimethamine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151854","Dapsone / Pyrimethamine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151776","Cidofovir Injectable Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151172","Didanosine Pill","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151171","Didanosine Oral Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1151170","Didanosine Oral Liquid Product","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1147337","Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1147336","emtricitabine 200 MG / Rilpivirine 25 MG / Tenofovir disoproxil fumarate 300 MG [Complera]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1147334","emtricitabine 200 MG / Rilpivirine 25 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1145805","emtricitabine / Rilpivirine / tenofovir disoproxil Oral Tablet [Complera]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1145803","Complera","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1145801","emtricitabine / Rilpivirine / tenofovir disoproxil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1145800","emtricitabine / Rilpivirine / tenofovir disoproxil Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","114289","Indinavir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","11413","Zidovudine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1117551","Gammaked 10 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1117550","Immunoglobulin G Injectable Solution [Gammaked]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1117549","Immunoglobulin G, Human 100 MG/ML [Gammaked]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1117548","Gammaked","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102282","Incivek 375 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102281","telaprevir Oral Tablet [Incivek]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102280","telaprevir 375 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102279","telaprevir Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102271","Rilpivirine 25 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102270","Rilpivirine","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102266","telaprevir 375 MG [Incivek]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102265","Incivek","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102262","telaprevir 375 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102261","telaprevir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102136","Victrelis 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102135","boceprevir Oral Capsule [Victrelis]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102134","boceprevir 200 MG [Victrelis]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102133","Victrelis","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102132","boceprevir 200 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102131","boceprevir Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102130","boceprevir 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1102129","boceprevir","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1095715","24 HR Viramune 400 MG Extended Release Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1095714","Nevirapine Extended Release Tablet [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1095713","Nevirapine 400 MG [Viramune]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1095712","24 HR Nevirapine 400 MG Extended Release Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1095711","Nevirapine Extended Release Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1095710","Nevirapine 400 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","108449","Trimethoprim 10 MG/ML Oral Suspension","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","108396","Retrovir 10 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","10831","Sulfamethoxazole / Trimethoprim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","10829","Trimethoprim","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","106876","isoniazid / Rifampin","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","105648","Proleukin 1.1 MG/ML Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","105337","Dapsone 100 MG / Pyrimethamine 12.5 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","105295","Rimactane 300 MG Oral Capsule","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1052660","Intelence 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1052659","etravirine 200 MG [Intelence]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1052658","etravirine 200 MG Oral Tablet","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1052657","etravirine 200 MG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","10171","sulfADIAZINE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1009212","Flebogamma 10 % Injectable Solution","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1009211","Immunoglobulin G, Human 100 MG/ML [Flebogamma]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1008789","efavirenz / lamiVUDine / tenofovir disoproxil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1008145","emtricitabine / tenofovir disoproxil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1007804","Acyclovir / Hydrocortisone","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.88","RxNorm","1007761","efavirenz / emtricitabine / tenofovir disoproxil","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.88","RxNorm","151358","Antabuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.96","SNOMED-Clinical Terms","417877006","Cocaine - pharmaceutical (substance)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.96","SNOMED-Clinical Terms","420721002","AIDS-associated disorder (disorder)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.96","SNOMED-Clinical Terms","111880001","Acute HIV","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.96","SNOMED-Clinical Terms","66214007","Substance Abuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.96","SNOMED-Clinical Terms","15167005","Alcohol abuse (disorder)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.96","SNOMED-Clinical Terms","16402000","Sickle cell trait (disorder)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD-9-CM","282.5","Sickle cell trait (disorder)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.42,"SICKLE-CELL THALASSEMIA WITH CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.59,"SICKLE-CELL TRAIT","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.64,"SICKLE-CELL/HB-C DISEASE WITH CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.68,"OTHER SICKLE-CELL DISEASE WITHOUT CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9","V78.2","SCREENING FOR SICKLE-CELL DISEASE OR TRAIT","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",43.2,"HIV CAUSING OTHER DISORDERS INVOLVING THE IMMUNE MECHANISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",42.1,"HIV CAUSING OTHER SPECIFIED INFECTIONS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.8,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",795.8,"POSITVE SEROLOGICAL OR VIRAL CULTURE FINDINGS FOR HIV","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.2,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",42.2,"HIV WITH SPECIFIED MALIGNANT NEOPLASMS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.9,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",43.9,"HIV-ACQUIRED IMMUNODEFICIENCY SYNDROME RELATED COMPLEX UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",42,"HIV WITH SPECIFIED INFECTIONS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.4,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",44.9,"HIV INFECTION UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.3,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.5,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",42.9,"HIV-ACQUIRED IMMUNODEFICIENCY SYNDROME UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",43.3,"HIV CAUSING OTHER SPECIFIED DISORDERS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176.1,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",43.1,"HIV CAUSING SPECIFIED DISEASES OF THE CENTRAL NERVOUS SYSTEM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",176,"KAPOSIS SARCOMA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",795.71,"NONSPECIFIC SEROLOGIC EVIDENCE OF HUMAN IMMUNODEFICIENCY VIRUS [HIV]","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",79.53,"HUMAN IMMUNODEFICIENCY VIRUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",79.51,"HUMAN T-CELL LYMPHOTROPHIC VIRUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",79.59,"OTHER SPECIFIED RETROVIRUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",79.52,"HUMAN T-CELL LYMPHOTROPHIC VIRUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9",42,"HUMAN IMMUNODEFICIENCY VIRUS HIV DISEASE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9","V08.","ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS [HIV] INFECTION STATUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"HIV/AIDS information sensitivity","2.16.840.1.113883.6.103","ICD9","V65.44","HUMAN IMMUNODEFICIENCY VIRUS HIV COUNSELING","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.1,"ALCOHOL-INDUCED PERSISTING AMNESTIC DISORDER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.2,"ALCOHOL-INDUCED PERSISTING DEMENTIA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.3,"ALCOHOL-INDUCED PSYCHOTIC DISORDER WITH HALLUCINATIONS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.4,"IDIOSYNCRATIC ALCOHOL INTOXICATION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.5,"ALCOHOL-INDUCED PSYCHOTIC DISORDER WITH DELUSIONS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.8,"OTHER SPECIFIED ALCOHOLIC PSYCHOSIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.9,"UNSPECIFIED ALCOHOL-INDUCED MENTAL DISORDERS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",292.84,"DRUG-INDUCED MOOD DISORDER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.41,"AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.13,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.02,"ALCOHOL ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.01,"ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.72,"COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.23,"CANNABIS ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.52,"OPIOID ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.51,"HALLUCINOGEN DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.93,"UNSPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.63,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.32,"HALLUCINOGEN ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",357.5,"ALCOHOLIC POLYNEUROPATHY","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.03,"OPIOID TYPE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.72,"AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.82,"ANTIDEPRESSANT TYPE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.81,"COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.21,"CANNABIS ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.62,"COCAINE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.81,"ANTIDEPRESSANT TYPE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.02,"OPIOID TYPE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.73,"COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.31,"HALLUCINOGEN ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.71,"AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.33,"HALLUCINOGEN ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.53,"HALLUCINOGEN DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.91,"Other, mixed, or unspecified drug abuse, continuous ","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.32,"CANNABIS DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.43,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.52,"HALLUCINOGEN DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.31,"CANNABIS DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.73,"AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.92,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.83,"ANTIDEPRESSANT TYPE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.11,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.41,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.03,"ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.53,"OPIOID ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.43,"AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.83,"COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.12,"TOBACCO USE DISORDER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.22,"COCAINE DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.02,"ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.62,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.22,"CANNABIS ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.12,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.71,"COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.01,"OPIOID TYPE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.51,"OPIOID ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.92,"OTHER MIXED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.42,"AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.91,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.21,"COCAINE DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.61,"COCAINE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.61,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.39,"OTHER CANNABIS DEPEND","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.01,"ALCOHOL ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.42,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.11,"TOBACCO USE DISORDER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.93,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.23,"COCAINE DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.03,"ALCOHOL ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.92,"UNSPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.91,"UNSPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.13,"TOBACCO USE DISORDER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.63,"COCAINE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.82,"COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.5,"HALLUCINOGEN DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.8,"ANTIDEPRESSANT TYPE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.8,"COMBINATIONS OF DRUG DEPENDENCE EXCLUDING OPIOID TYPE DRUG","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305,"ALCOHOL ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.1,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.3,"HALLUCINOGEN ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.9,"OTHER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.7,"AMPHETAMINE OR RELATED ACTING SYMPATHOMIMETIC ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304,"OPIOID TYPE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.1,"TOBACCO USE DISORDER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.6,"COCAINE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.3,"CANNABIS DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.4,"AMPHETAMINE AND OTHER PSYCHOSTIMULANT DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.2,"COCAINE DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",291,"ALCOHOL WITHDRAWAL DELIRIUM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.4,"SEDATIVE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.6,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303.9,"OTHER AND UNSPECIFIED ALCOHOL DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.7,"COMBINATIONS OF OPIOID TYPE DRUG WITH ANY OTHER DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",303,"ACUTE ALCOHOLIC INTOXICATION IN ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.2,"CANNABIS ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.9,"UNSPECIFIED DRUG DEPENDENCE NEC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.5,"OPIOID ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9","V11.3","PERSONAL HISTORY OF ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.122,"MEPROBAMATE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.49,"OTHER PSYCHOSTIMULANT DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.502,"MORPHINE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.428,"BARBITURATES ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.329,"OTHER HALLUCINOGEN ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.408,"BARBITURATES ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.511,"METHADONE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.929,"OTHER MIXED/UNSPEC DRUG ABUSE NEC INCL CAFFEINE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.709,"OTHER RELATED ACTING SYMPATHOMIMETIC ABUSE NEC UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.422,"MEPROBAMATE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.129,"OTHER SEDATIVE OR HYPNOTIC DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.46,"VALIUM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.423,"NOLUDAR METHYPRYLOME ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.523,"OPIUM ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.421,"PRELUDIN DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.33,"CANNABIS DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.79,"OTHER RELATED ACTING SYMPATHOMIMETIC ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.417,"DORIDEN GLUTETHIMIDE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.519,"OTHER OPIOD ABUSE NEC CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.539,"OTHER HALLUCINOGEN DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.701,"PRELUDIN ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.239,"OTHER CANNABIS ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.104,"PARALDEHYDE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.919,"UNSPECIFIED DRUG DEPENDENCE NEC CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.731,"PRELUDIN ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.411,"PRELUDIN DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.15,"PLACIDYL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",291.21,"DEMENTIA ASSOCIATED WITH ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.137,"DORIDEN GLUTETHIMIDE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.109,"OTHER SEDATIVE OR HYPNOTIC DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.436,"VALIUM DIAZEPAM ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.401,"PRELUDIN DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.132,"MEPROBAMATE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.405,"PLACIDYL ETHCHLORUYNOL ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",291.2,"DEMENTIA ASSOCIATED WITH ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.439,"OTHER SEDATIVE OR HYPNOTIC ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.126,"VALIUM DIAZEPAM DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.229,"OTHER CANNABIS ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.14,"PARALDEHYDE DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.59,"OTHER OPIOID ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.309,"OTHER CANNABIS DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.113,"NOLUDAR METHYPRYLOME DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.719,"OTHER RELATED ACTING SYMPATHOMIMETIC ABUSE NEC CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.127,"DORIDEN GLUTETHIMIDE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.412,"MEPROBAMATE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.531,"METHADONE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.18,"BARBITURATE DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.09,"OTHER OPIOID TYPE DEPEN","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.106,"VALIUM DIAZEPAM DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.431,"PRELUDIN DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.929,"UNSPECIFIED DRUG DEPENDENCE NEC EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.418,"BARBITURATES ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.409,"OTHER PSYCHOSTIMULANT DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.133,"NOLUDAR METHYPRYLOME DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.432,"MEPROBAMATE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",291.23,"DEMENTIA ASSOCIATED WITH ALCOHOLISM SEVERE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.339,"OTHER CANNABIS DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.522,"MORPHINE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.429,"OTHER PSYCHOSTIMULANT DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.404,"PARALDEHYDE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.135,"PLACIDYL ETHCHLORUYNOL DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.19,"OTHER SEDATIVE OR HYPNOTIC DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.105,"PLACIDYL ETHCHLORUYNOL DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.021,"METHADONE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.402,"MEPROBAMATE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.45,"PLACIDYL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.103,"NOLUDAR METHYPRYLOME DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.434,"PARALDEHYDE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.102,"MEPROBAMATE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.115,"PLACIDYL ETHCHLORUYNOL DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.125,"PLACIDYL ETHCHLORUYNOL DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.431,"LIBRIUM ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.002,"MORPHINE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.033,"OPIUM DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.209,"OTHER CANNABIS ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.437,"DORIDEN GLUTETHIMIDE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.011,"METHADONE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.112,"MEPROBAMATE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.118,"BARBITURATES DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.329,"OTHER CANNABIS DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.032,"MORPHINE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.421,"LIBRIUM ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.401,"LIBRIUM ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.124,"PARALDEHYDE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.107,"DORIDEN GLUTETHIMIDE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.131,"LIBRIUM DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.138,"BARBITURATES DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.429,"OTHER SEDATIVE OR HYPNOTIC ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.435,"PLACIDYL ETHCHLORUYNOL ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.003,"OPIUM DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.101,"LIBRIUM DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.16,"VALIUM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.406,"VALIUM DIAZEPAM ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.99,"UNSPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.108,"BARBITURATES DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.219,"OTHER CANNABIS ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.438,"BARBITURATES ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.031,"METHADONE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.013,"OPIUM DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.134,"PARALDEHYDE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.319,"OTHER CANNABIS DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.012,"MORPHINE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.403,"NOLUDAR METHYPRYLOME ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.29,"OTHER CANNABIS USE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.513,"OPIUM ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.414,"PARALDEHYDE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.509,"OTHER HALLUCINOGEN DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.427,"DORIDEN GLUTETHIMIDE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.309,"OTHER HALLUCINOGEN ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.029,"OTHER OPIOD DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.503,"OPIUM ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.47,"DORIDEN","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.407,"DORIDEN GLUTETHIMIDE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.919,"OTHER MIXED/UNSPEC DRUG ABUSE NEC INCL CAFFEINE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.509,"OTHER OPIOD ABUSE NEC UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.411,"LIBRIUM ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.909,"OTHER MIXED/UNSPEC DRUG ABUSE NEC INCL CAFFEINE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.117,"DORIDEN GLUTETHIMIDE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.711,"PRELUDIN ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.48,"BARBITURATES ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.532,"MORPHINE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.426,"VALIUM DIAZEPAM ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.419,"OTHER PSYCHOSTIMULANT DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.121,"LIBRIUM DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.023,"OPIUM DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.001,"METHADONE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.433,"NOLUDAR METHYPRYLOME ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.533,"OPIUM ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.019,"OTHER OPIOD DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.512,"MORPHINE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.519,"OTHER HALLUCINOGEN DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.44,"PARALDEHYDE ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.319,"OTHER HALLUCINOGEN ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.339,"OTHER HALLUCINOGEN ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.022,"MORPHINE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.939,"UNSPECIFIED DRUG DEPENDENCE NEC IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.116,"VALIUM DIAZEPAM DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.99,"OTHER","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.909,"UNSPECIFIED DRUG DEPENDENCE NEC UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.49,"OTHER SEDATIVE OR HYPNOTIC ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.039,"OTHER OPIOD DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.416,"VALIUM DIAZEPAM ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.009,"OTHER OPIOD DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.425,"PLACIDYL ETHCHLORUYNOL ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.111,"LIBRIUM DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.39,"OTHER HALLUCINOGEN ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.119,"OTHER SEDATIVE OR HYPNOTIC DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.415,"PLACIDYL ETHCHLORUYNOL ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.128,"BARBITURATES DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.136,"VALIUM DIAZEPAM DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.139,"OTHER SEDATIVE OR HYPNOTIC DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.17,"DORIDEN","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.409,"OTHER SEDATIVE OR HYPNOTIC ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.123,"NOLUDAR METHYPRYLOME DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.413,"NOLUDAR METHYPRYLOME ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.529,"OTHER OPIOD ABUSE NEC EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.439,"OTHER PSYCHOSTIMULANT DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.721,"PRELUDIN ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.419,"OTHER SEDATIVE OR HYPNOTIC ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.539,"OTHER OPIOD ABUSE NEC IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.424,"PARALDEHYDE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.739,"OTHER RELATED ACTING SYMPATHOMIMETIC ABUSE NED IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.114,"PARALDEHYDE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.521,"METHADONE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.529,"OTHER HALLUCINOGEN DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.729,"OTHER RELATED ACTING SYMPATHOMIMETIC ABUSE NEC EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.59,"OTHER HALLUCINOGEN DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",291.22,"DEMENTIA ASSOCIATED WITH ALCOHOLISM","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.501,"METHADONE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.43,"AMPHETAMINE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.93,"PHENCYCLIDINE PCP DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.6,"COCAINE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.41,"CHLORAL HYDRATE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.61,"PHENCYCLIDINE PCP DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.31,"LSD ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.9,"PHENCYCLIDINE PCP DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.4,"CHLORAL HYDRATE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.21,"MARIJUANA ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.91,"PHENCYCLIDINE PCP ABUSE INCLUDES CAFFEINE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.619,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.31,"MARIJUANA DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.9,"PHENCYCLIDINE PCP ABUSE INCLUDES CAFFEINE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.51,"LSD DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.73,"AMPHETAMINE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.4,"AMPHETAMINE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.3,"LSD ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304,"HEROIN DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.22,"MARIJUANA ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.52,"LSD DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.3,"MARIJUANA DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.33,"LSD ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.72,"AMPHETAMINE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.23,"MARIJUANA ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.1,"TOBACCO USE DISORDER UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.629,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.12,"CHLORAL HYDRATE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.01,"HEROIN DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.7,"AMPHETAMINE ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.33,"MARIJUANA DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.32,"MARIJUANA DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.02,"HEROIN DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.53,"HEROIN ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.42,"AMPHETAMINE DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.03,"HEROIN DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.52,"HEROIN ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.639,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.62,"PHENCYCLIDINE PCP DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.63,"PHENCYCLIDINE PCP DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.91,"PHENCYCLIDINE PCP DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.92,"PHENCYCLIDINE PCP ABUSE INCLUDES CAFFEINE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.1,"CHLORAL HYDRATE DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.609,"OTHER SPECIFIED DRUG DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.11,"CHLORAL HYDRATE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.41,"AMPHETAMINE DEPENDENCE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.71,"AMPHETAMINE ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.43,"CHLORAL HYDRATE ABUSE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.92,"PHENCYCLIDINE PCP DEPENDENCE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.13,"CHLORAL HYDRATE DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.51,"HEROIN ABUSE CONTINUOUS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.42,"CHLORAL HYDRATE ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.5,"LSD DEPENDENCE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.93,"PHENCYCLIDINE PCP ABUSE INCLUDES CAFFEINE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.53,"LSD DEPENDENCE IN REMISSION","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.5,"HEROIN ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.32,"LSD ABUSE EPISODIC","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",305.2,"MARIJUANA ABUSE UNSPECIFIED","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",304.6,"PHENCYCLIDINE PCP DEPENDENCE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9",291.89,"OTHER SPECIFIED ALCOHOL-INDUCED MENTAL DISORDERS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Drug abuse information sensitivity","2.16.840.1.113883.6.103","ICD9","V65.42","COUNSELING ON SUBSTANCE USE AND ABUSE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.81,"ALCOHOL WITHDRAWAL","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"Alcohol Abuse and Alcoholism Information","2.16.840.1.113883.6.103","ICD9",291.82,"ALCOHOL INDUCED SLEEP DISORDERS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.5,"SICKLE-CELL TRAIT","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.61,"HB-SS DISEASE WITHOUT CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.62,"HB-SS DISEASE WITH CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.63,"SICKLE-CELL/HB-C DISEASE WITHOUT CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.69,"OTHER SICKLE-CELL DISEASE WITH CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.6,"SICKLE-CELL DISEASE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.44,"SICKLE-CELL THALASSEMIA","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.41,"SICKLE-CELL THALASSEMIA WITHOUT CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.5,"SICKLE-CELL TRAIT HB-AS GENOTYPE","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.64,"SICKLE-CELL/HB-C DISEASE WITH CRISIS","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"SICKLE CELL","2.16.840.1.113883.6.103","ICD9",282.65,"SICKLE-CELL DISEASE/HB-E","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"SCA","sickle cell anemia","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"42 CFR Part 2 - CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS","http://www.nlm.nih.gov/research/umls/rxnorm","RxNorms",151358,"Antabuse","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"42 CFR Part 2 - CONFIDENTIALITY OF HIV RELATED PATIENT RECORDS","http://snomed.info/sct","SNOMED",62479008,"Acquired immune deficiency syndrome (disorder)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"HIV","HIV/AIDS information sensitivity ","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
"42 CFR Part 2 - CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS","http://snomed.info/sct","SNOMED",26416006,"Drug abuse (disorder)","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"ETH","substance abuse information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"42 CFR Part 2 - CONFIDENTIALITY OF MENTAL HEALTH RELATED PATIENT RECORDS","http://www.nlm.nih.gov/research/umls/rxnorm","RxNorms",82728,"Zoloft","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"PSY","psychiatry information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"42 CFR Part 2 - CONFIDENTIALITY OF MENTAL HEALTH RELATED PATIENT RECORDS","http://snomed.info/sct","SNOMED",47505003,"PTSD","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"PSY","psychiatry information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"R","Restricted"
"42 CFR Part 2 - CONFIDENTIALITY OF MENTAL HEALTH RELATED PATIENT RECORDS","http://snomed.info/sct","SNOMED",370143000,"Major depression disorder","http://terminology.hl7.org/CodeSystem/v3-ActCode",,"PSY","PSY information sensitivity","http://terminology.hl7.org/CodeSystem/v3-Confidentiality",,"V","Very Restricted"
